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Skeletal muscle insulin resistance is a common precursor to type II diabetes. 
Phytochemicals in fruits have shown to have bioactive properties that could alleviate 
some of the symptoms and causes of insulin resistance in peripheral tissues. In this 
thesis, stone fruits of peach, plum, and nectarine were viewed for their bioactive 
properties against insulin resistant murine C2C12 myotubes in vitro. Fruits were 
characterized using HPLC-DAD and TLC, removed of sugars and organic acids by SPE 
reverse phase C18 silica gel, and tested on a palmitic acid induced insulin resistant 
skeletal muscle model for cytotoxicity levels and glucose 6-phosphate accumulation. 
Peach extracts investigated in depth analysis in this study. Using SPE the peach extract 
was fractionated into major phenolic compound categories, identified with HPLC-DAD, 
and quantified with wet based chemistry assays. The standardized peach fractions were 
tested on the cell model for cytotoxicity levels, glucose uptake, glucose 6-phosphate, 
ROS accumulation, and immunochemistry. 
Isolated and identified extracts were used at 0-300 µg/mL for cytotoxicity 
testing. From these results, stone fruit phenolic levels used for glucose 6-phosphate 
quantification were 1, 10, and 100 µg/mL. Of the stone fruits, peach and nectarine had 
the most pronounced effect on glucose 6-phosphate concentration at 1 and 10 µg/mL. 
Further isolated peach extract was separated using SPE, identified using HPLC-DAD 
and quantified with a wet based chemical assay. These peach phenolic fractions were 




most effective doses  in the cell used for further assays (phenolic acid fraction: 1µg/mL; 
anthocyanin and flavonoid fractions: 0.1µg/mL; catechin fraction: 0.5 µg/mL). All 
fractions were able to restore intracellular glucose 6-phosphate to levels comparable to 
normal and control cells with the exception of F3 which showed no difference from IR 
induced cells. The fractions had no significant effect on ROS accumulation but were 
able to increase AKT phosphorylation and decrease phosphorylation of negative 
regulators of insulin signaling (JNK and IRS1ser307). Further research is needed to view 
if these compounds act directly on insulin receptors, or work through the AMPK 
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G6P   Glucose 6-phosphate 
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AcCoA  Acetyl Coenzyme A 
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1. INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Introduction  
 Type II diabetes mellitus is a chronic metabolic disorder that currently affects the 
US population, with over 6% diagnosed as diabetic. In 2011 the American Diabetes 
Association (ADA) reported that there are currently over 18 million Americans 
diagnosed with diabetes and almost 80 million with pre-diabetes. Type II diabetes 
mellitus results from a genetic mixture of predisposition, behavioral, and environmental 
risk factors and is characterized by β-cell dysfunction from the pancreas, excessive 
glucose production from the liver and tissue insulin resistance from the adipose and 
skeletal muscle.1, 2Over time, type II diabetes mellitus can often lead to other health 
complications including cardiovascular disease (CVD), high blood pressure, kidney 
disease and neuropathy. 
 Insulin resistance (IR), a common precursor to type II diabetes, can be developed 
as far as 10 years prior to diabetes diagnosis due to normal β-cell function3 as pancreatic 
insulin secretion overcompensates for the reduced insulin tissue response.4 IR occurs in 
insulin sensitive tissues (adipose, skeletal muscle, and liver) when the body develops a 
decreased response to insulin release most likely caused by problems in the insulin 
signaling pathway, inflammatory pathways, accumulation of free fatty acids in the 
plasma, and/or decreased mitochondrial function in the cells.5 Therefore, treatments that 





 It has been stated many times in the past decade that having a diet rich in fruits 
and vegetables may reduce the occurrence of non-communicable diseases such as CVD, 
certain types of cancer, and type II diabetes. Specifically, the phytochemicals in fruits 
and vegetables have attracted great interest since the 1990s due to growing evidence of 
their beneficial effects on human health. Phytochemicals are plant secondary metabolites 
that largely contribute to plant fitness by antibiotic, antifungal, and antiviral mechanisms 
as well as protect the plants against pathogens and damage from UV light.6 Phenolic 
compounds are a class of phytochemicals defined by at least one or more phenol group 
structure and are very widely dispersed in the plant kingdom. There are over 8000 
phenolic compounds that have been identified in the plant kingdom and many have 
shown antioxidant, anti-inflammatory, anti-mutagenic, and anti-carcinogenic effects in 
different disease states in vitro, in vivo, and in human clinical trials. 
 Stone fruit cultivars contain a mixture of diverse phenolic compounds in their 
flesh and peel including hydroxycinnamates, chlorogenic and neo-chlorogenic acids, 
anthocyanidins, flavonols, quercitin derivatives, and procyanidin dimers and trimers.7 
There has been research on some of these individual compounds effect on insulin 
resistance such as chlorogenic acids from coffee consumption on insulin sensitivity8 and 
blueberry anthocyanins on glucose absorption and lipid metabolism in vivo and in vitro.9 
Current work will focus on phenolics isolated from stone fruit to view any potential 






1.2 Literature Review 
1.2.1 Type II Diabetes Mellitus 
 Type II diabetes mellitus occurs when there is an inability of insulin to promote 
sufficient glucose uptake in insulin sensitive tissues and prevent glucose output from 
liver. In healthy individuals there is a constant plasma glucose homeostasis due to an 
intrinsic feedback loop regulated by insulin and glucagon; both of these hormones 
function to maintain normal blood glucose levels. Normally, plasma glucose levels 
increase postprandial, which triggers the release of insulin from β-cell from the islets of 
the pancreas stimulating glucose uptake into adipose and skeletal muscle and promoting 
the storage of sugars as triglycerides and glycogen. Tissue insulin resistance plays a 
major role in the development of diabetes and can be acutely present for years before 
diagnosis occurs. Issues arising from tissue insulin resistance include uncontrolled 
fasting hepatic glucose production (HGP) from the liver and increased free fatty acid 
(FFA) release from the adipose, leading to further hindering of glucose uptake and 
glycogen synthesis in the skeletal muscle4. In this stage of insulin resistance, plasma 
glucose levels may remain normal as the secretory β-cells of the pancreas will 
overcompensate and release more insulin to the tissues to try to overcome the decreased 
sensitivity.   Eventually, the pancreatic β-cells will fail to compensate for the insulin 
resistance over a period of time leading to hyperglycemia. Chronic high blood glucose 
levels then progress the disease by further impairing insulin sensitivity and worsening β-
cell exhaustion. Some known risk factors that increase the odds of being diagnosed are 




diet, decreased energy expenditure, and genetic predisposition, considering factors such 
as ethnicity and immediate family history such as a parent with type II diabetes or 
gestational diabetes1. There are several current treatment methods available for type II 
diabetes, but almost all of them have side effects or downsides to their prescriptions.  
1.2.2 Glucose Homeostasis 
 In the post absorptive state (overnight fasting), the main source of plasma 
glucose comes from the liver, with a small amount being produced by the kidneys. The 
liver is the most important site of insulin-mediated basal glucose release, with about half 
of hepatic glucose production (HGP) from glycogenolysis and half from 
gluconeogenesis10. Most of this glucose from the liver is used by insulin independent 
tissues, approximately 50% of all glucose disposals occurs in the brain and around 25% 
in the splanchnic area (gastrointestinal tract and the liver). The remaining 25% of 
glucose uptake occurs in the insulin dependent tissues, primarily skeletal muscle. 
Skeletal muscle lacks glucose 6-phosphatase so there is no glycogenolysis present in 
muscle to provide glucose release, but instead the skeletal muscle will export amino 
acids and other substrates to the liver for gluconeogenesis11. 
 In the absorptive state, there is a rise in blood glucose levels from ingested food, 
which rapidly stimulates insulin release into the portal vein from the β-cells of the 
pancreas, which then directs the body to store fuel by increasing glucose transport 
through the insulin signaling pathway in sensitive tissues. Insulin promotes the 
deposition of glycogen in the liver, triglycerides in the adipose, and activates glucose 




secretion and lowers serum FFA concentrations which contribute to the decline in HGP. 
Skeletal muscle is the major site of insulin-mediated dietary glucose uptake through 
stimulation of the insulin-sensitive glucose transport system. After a meal, 
approximately 80-85% of glucose disposal in insulin stimulated tissues occurs in the 
skeletal muscle. Disposal of glucose in the muscle tissue is essential in preventing 
hyperglycemia. Insulin will initiate the uptake of glucose into the skeletal muscle and 
enhance the glycogen synthase activity through the regulation of a cyclic adenosine 
monophosphate (cAMP) mediated cascade that converts glucose into glycogen in the 
cells4. After glucose enters the skeletal muscle it can be converted into glycogen (70% of 
glucose uptake) or enter the glycolytic pathway (90% glucose oxidation and 10% 
anaerobic glycolysis).12 Although fat account for a small amount of glucose disposal 
(around 5%) it plays an important role in the maintenance of total body glucose 
homeostasis by regulation of lipolysis with subsequent release of glycerol and FFAs into 
the bloodstream. 
1.2.3 The Insulin Signaling Pathway  
 Insulin is a hormone that regulates many pathways including aiding in the 
synthesis of protein, glucose homeostasis, and glycogen storage in muscle. Released 
insulin travels to the muscle and adipose for glucose uptake and to the liver to suppress 
HGP. Adipose accounts for only a small amount of total body glucose uptake but is a 
major regulator of glucose homeostasis. Released insulin inhibits lipolysis and prevents 
the release of FFAs from adipocytes; the decline in plasma FFA concentrations leads to 




HGP.13The tissue responsible for the major site of glucose disposal in the body is the 
skeletal muscle. The insulin signaling cascade in myofibers initiates with the post 
prandial release of insulin from the β-cells. Insulin travels to the muscle tissue and binds 
to its receptor on the muscle cell surface which initiates a signaling cascade of events. 
The insulin receptor is a tetrameric protein than consists of two extracellular α-subunits 
containing a ligand binding site and two trans-membrane β-subunits which have a 
tyrosine protein kinase catalytic domain. The two α and β subunits are held together by 
disulfide bonds and the receptor is dimeric in its inactive state. The insulin receptor 
signals the insulin receptor substrates (IRS) through docking proteins.14 Insulin binds to 
the α-subunits of the receptor, activating one of the β-subunits which lead to the insulin 
receptor’s auto phosphorylation. This leads to the activation of the Phosphoinositide 3-
Kinase/Protein Kinase B (PI3K/PKB) pathway, which is responsible for most metabolic 
actions of insulin, and the activation of the Ras-Mitogen Activated Protein Kinase 
(MAPK) pathway, which regulates expression of some genes and cooperates with PI3K 
to control cell growth and differentiation.15 
 The insulin receptor tyrosine kinase activity promotes the tyrosine 
phosphorylation of the Insulin Receptor Substrate 1 (IRS1) protein. These 
phosphotyrosine residues act as docking sites and from complexes with many Src 
homology region 2 (SH2) domain-containing proteins, including the p85 regulatory 
subunit of PI3K. PI3K is a heterodimeric enzyme composed of a p85 regulatory subunit 
and a p110 catalytic subunit. Once p85 on PI3K associates with IRS1 it activates protein 




catalyzes the formation of the lipid second messenger phosphatidylinositol-3,4,5-
triphosphate (PIP3) from plasma membrane lipid phosphatidylinositol-4,5-bisphosphate 
(PIP2). Signaling proteins with Pleckstrin homology (PH) domains can bind directly to 
PIP3 and become activated, including serine threonine kinases like AKT and 3-
phosphoinositide-dependent protein kinase 1 (PDK1)16. Association with PIP3 at the 
membrane brings the two proteins in close proximity and PDK1 can then phosphorylate 
AKT16. AKT contains an N-terminal PH domain and a C-terminal catalytic domain. 
The first terminal 100 amino acids possess the PH domain that can bind to 
phospholipids. There is a short glycine rich region bridging the PH domain to the 
catalytic domain. The carboxy-terminal 70 amino acid tail contains the putative 
regulatory domain17. AkT2 is the main regulator of glucose uptake in the insulin 
signaling pathway and has a high concentration in the insulin sensitive tissues.18, 19 AKT 
is phosphorylated by PDK1 at threonine 308 (Thr308) and at serine 473 (Ser473) by 
PDK2 or auto phosphorylation. This promotes the full activation of AKT which then 
detaches from the plasma membrane and translocates to the cytosol and the nucleus. 
Thr308 resides within the activation loop of the linase domain and Ser473 lies in the 
carboxy-terminal tail. The activation of AKT leads to the translocation of intracellular 
glucose transport vesicles (GLUTs) to the cell membrane to uptake free glucose into the 
cell. GLUT1 is involved in skeletal muscle basal glucose uptake and GLUT4 is the 
primary insulin responsive glucose transporter in muscle. In the absence of insulin over 
90% of the vesicles are found intracellularly. In the presence of insulin they translocate 




cell13. The exact molecular mechanism of how AKT activation leads to GLUT4 
translocation is still being researched, however the TBC1D4 (TBC1 domain family 
member 4), also known as Rab-GAP AS160, has been discovered as a direct target of 
downstream AKT activation20. The model is that AKT-mediated phosphorylation of 
some sites on AS160 inhibits GAP (GTPase-Activating Protein) activity and thus 
allowing a Rab-family GTPase to become GTP loaded and stimulate GLUT4 vesicles 
translocation to the membrane surface.21At the cell surface, GLUT4 permits facilitated 
diffusion of glucose down a concentration gradient into the insulin sensitive tissue. Once 
within the cells, glucose is rapidly phosphorylated by hexokinase to glucose 6-phosphate 
(G6P) which then is polymerized into glycogen, or enters the glycolysis cycle.  
1.2.4 Glucose Metabolism 
  Glucose enters the cells via GLUT transporters from the insulin signaling 
pathway. That glucose is immediately converted into G6P by hexokinase in skeletal 
muscle. G6P is further converted into  fructose 1,6-bisphosphate (F16BP) which 
converts to glyceraldehyde 6-phosphate and then to 1,3-phosphoglycerate which finally 
gets converted into pyruvate which will end up as acetyl-coenzyme A (AcCoA) and 
oxaloacetate which will enter the mitochondria where they produce Reactive Oxygen 
Species (ROS) due to the Kreb’s cycle production of NADH, H+, and FADH2. During 
hyperglycemia, elevated glucose levels induce the TCA cycle electron donor 






1.2.5 Oxidative Stress and Reactive Oxygen Species 
 Reactive Oxygen Species (ROS) are naturally occurring in living organisms and 
are found as either waste products from biological processes or that which is produced 
intentionally in a signaling pathway, cell defense system, or during synthesis or 
breakdown. The mitochondria are the largest source of ROS in the body, due to 
oxidative phosphorylation and the electron transport chain processes. Major known 
sources for overproduction of ROS in the cells include endoplasmic reticulum (ER) 
stress, advance glycation end products (AGEs), nitric oxide synthase and lipid 
peroxidases, lipotoxicity, glucose metabolism, and Tumor Necrosis factor alpha 
(TNFα).23 Overproduction of ROS has been known to be associated with T2DM and 
insulin resistance.24 To alleviate the toxic buildup of ROS from the cellular processes, 
the body produces enzymes such as superoxide dismutase (SOD) to repair the oxidative 
damage to the cell. Oxidative stress occurs in cells when there is an imbalance between 
the antioxidant (AOX) available for reactions and the oxygen radicals, such as ROS, 
present in the cell system. Studies have shown that an increase in mitochondrial 
oxidative stress may play a role in type II diabetes and insulin resistance. 25-34  
 Oxidative stresses such as ROS are known to activate c-Jun N-terminal kinase 
(JNK), a mitogen-activated protein kinase family member. JNK may also be activated by 
ER stress, free fatty acids, MAPKs, MAP2Ks, MAP3Ks, as well as many other cellular 
events.35 ROS accumulation in the cell promotes prolonged activation of JNK by 




fat and muscle tissue in mice placed on a high fat diet, and genetically (ob/ob) obese 
mice.36-37 
 JNK is important for the regulation of cell death and survival, differentiation, 
proliferation, ROS accumulation, metabolism, insulin signaling, and many other cell 
functions. Free fatty acid accumulation in the cell can lead to the activation of oxidative 
stress, which leads to ER stress lipid peroxidation which may activate JNK1 leading to 
the disruption of the insulin pathway through the activation of IRS1 serine 307 
phosphorylation.  Mitochondrial stress will activate JNK and p38 MAPK in a Ca2+ 
dependent manner and represses IRS1threonine activation through ATF3 in a Ca2+ and 
JNK dependent manner.38 The JNK specific phosphorylation site in the insulin signaling 
pathway is IRS1 serine 307 phosphorylation. Ser307 phosphorylation of IRS1 by JNK 
decreases the threonine phosphorylation capabilities, therefore inhibiting the insulin 
signaling pathway, as threonine phosphorylation is necessary to activate AKT in the 
PI3K pathway.39-41 Mitochondrial dysfunction will increase intramyocellular lipid 
metabolites which may activate ser/thr kinases and suppress insulin signaling before the 
phosphorylation of IRS1.42-45 
1.2.6 Insulin Resistance 
 Insulin resistance is a fundamental predictor of diabetes development and is also 
linked to other complications such as hypertension, hyperlipidemia, insulin resistance 
syndrome (syndrome X), renal failure, gestational diabetes and atherosclerosis. Insulin 
resistance refers to the relationship between insulin release and its ability to stimulate 




higher than normal insulin concentrations are needed to achieve a normal metabolic 
response, or when normal insulin concentrations fail to establish a normal metabolic 
response.12 In the basal state, insulin resistance occurs in the liver initiated by too much 
hepatic glucose production (HGP). An excess amount of HGP is the main cause of 
fasting hyperglycemia and is caused by increases in gluconeogenesis and 
glycogenolysis. In the insulin stimulated state, skeletal muscle is the primary site of 
insulin resistance and is responsible for an increase in plasma glucose concentrations 
above the baseline following ingestion.47While there are many contributing factors to the 
development of insulin resistance and eventually, diabetes, the accumulation of plasma 
FFAs is a large contributor to the development of insulin resistance. Previously it was 
thought that the cellular mechanisms behind this connection were due to a competition 
between fatty acids and glucose oxidation known as the Randle cycle. Briefly, an 
increase in fatty acid concentration results in an elevation of the intra-mitochondrial 
acetyl CoA/CoA and NADH/NAD+ ratios with the inactivation of pyruvate 
dehydrogenase which leads to an increase in citrate concentration and therefore 
inhibiting phosphofructokinase. FFAs could also decrease muscle insulin sensitivity by 
increasing the flux of G6P to the hexosamine biosynthetic pathway; with an increase in 
UDP-N-acetyl glucosamine, G6P would be converted to F6P, resulting in the elevation 
of intramuscular hexosamines, which have been shown to decrease glucose transport and 
GLUT4 translocation.48 In reality, a more complex effect of fatty acids on insulin 
signaling exists. One theory is that FFAs interfere with insulin signaling through PKC 




decreased glucose transport. Another concept of the effect on fatty acids on the insulin 
signaling cascade involve an increase in intracellular fatty acid metabolites like 
diacylglycerol (DAG), fatty acyl CoA, and ceramides that can lead to the 
phosphorylation of serine/threonine sites on IRS-1 that affect PKB and other 
downstream proteins in the pathway.1, 49 FFAs also increase HGP, by stimulating key 
enzymes and by providing energy from gluconeogenesis while the glycerol released 
during triglyceride hydrolysis serves as a substrate for gluconeogenesis.12 Many papers 
have reported that saturated FFAs do initiate an insulin resistant response in cellular 
tissues, but that unsaturated FFAs do not.50-51 Specifically, hexadecanoic acid (palmitic 
acid, C16:0), one of the most comply found fatty acid in nature, has been known to 
induce insulin resistance in vitro.  
1.2.7 Current Treatments for Type II Diabetes Mellitus 
 In a study of lifestyle changes (keeping food and exercise logs, increasing fiber 
and vegetable consumption while decreasing fat, sugar, salt and alcohol consumption as 
well as increasing exercise and changing the type of fats consumed in the diet) 
development of diabetes among subjects with impaired glucose tolerance was 58% lower 
in the intervention group than the control group.52 
 During bouts of exercise, there is an increase in GLUT4 translocation to the 
sarcolemmal membrane and the t tubules where glucose uptake occurs in pathways 
independent from insulin stimulation.  The glucose uptake is activated by muscle 
contractions, exercise induced production of nitric oxide and bradykinin. Skeletal muscle 




ions (Ca2+) also play an important role in insulin-independent glucose uptake. 5 – 
adenosine monophosphate-activated protein kinase (AMP kinase) is activated by a 
decrease in cellular energy charge during exercise. The enhanced glucose uptake from 
exercise in type 2 diabetic patients shows to persist into the immediate post exercise 
period for up to 20 hours after a workout and endurance exercise training also leads to 
improvement in insulin action on skeletal muscle glucose metabolism. After six weeks 
of exercise training by insulin resistant offspring of diabetic subjects, there was an 
enhancement of insulin stimulated glucose transport and phosphorylation in skeletal 
muscle.54 
 Outside of clinical trials, there is an uncertainty that real populations can 
maintain diet and exercise interventions for long term period of time. Also, in some 
diabetic or high risk individuals such as the elderly and the disabled, it is difficult to add 
an exercise regime. This is where the use of pharmaceutical aids begins. Current and 
past drugs used for the prevention and treatment of T2DM include biguanides 
(metformin), thiazolidinediones (TZDs) (rosiglitazone, troglitazone), sulfonyurea 
derivatives, exogenous insulin, α-glucosidase inhibitors (acarbose), and lipase inhibitors 
(orlistat).  
 The biguanide metformin is one of the most thoroughly studied drug used for 
diabetes prevention. Metformin has an exceptional safety record and a low cost 
affordability and so it is a popular option for diabetes prevention.55 Metformin works 
independently of the pancreas. It improves insulin sensitivity in the liver by decreasing 




cardiovascular options. It is not as effective on its effects on insulin resistance, 
inflammation, and vascular function as compared to TZDs.56 Metformin has also been 
shown to cause adverse gastrointestinal disturbances and, rarely, lactic acidosis and 
therefore should not be used in patients with impaired renal or hepatic function.4 
 Thiazolidinedione drugs have also been shown to enhance insulin sensitivity as 
well as enhance vascular function of type 2 diabetic patients. TZDs are synthetic 
selective ligands of the nuclear transcription factor peroxisome-proliferator-activated 
receptor γ (PPARγ) in adipose tissue.57 TZDs activate PPARγ which alters the 
distribution of triglycerides from storage which reduces FFAs in the plasma. They also 
reduce the circulating concentrations of pro-inflammatory cytokines such as TNFα and 
IL-6, which are associated with insulin resistance development through inflammatory 
pathways.56 There are signs of cross talk between TZDs effect on adipose to skeletal 
muscle, liver and pancreatic β-cells which could explain the overall improvement of 
insulin action and secretion when taking TZDs. These drugs are better tolerated than 
metformin without GI tract effects; however these drugs do show to increase weight gain 
and fluid retention in patients. There is also a concern for some patients on TZDs of 
congestive heart failure, although the cases reported are quite rare. From a clinical case 
of rosiglitazone treatment, the frequency of congestive heart failure increased from the 
placebo, but with only few cases reported.55 In another case study where the risk of 
congestive heart failure was higher in diabetic patients given TZD over controls they 
determined that the patients, because they did not have previous history of congestive 




and diastolic dysfunction in the patients.57 There are also some rare risks of hepatic 
toxicity and anemia with the use of these drugs.58 
 Sulfonylurea derivatives act by closing the pancreatic islet cell potassium 
channels to increase insulin secretion. They bind directly to cell surface receptors that 
induce the closure of adenosine triphosphate-dependent potassium (KATP) channels 
which leads to membrane depolarization and an influx of extracellular calcium which 
prompts insulin secretion. With the insulin stimulating action that sulfonylurea 
derivatives possess, there is often a chance of extreme hypoglycemia.4 
 Other preventative drugs include α-glucosidase inhibitors, mainly acarbose, and 
intestinal lipase inhibitors, such as Orlistat. Both of these drugs have a high drop-out rate 
and limited acceptability as potential oral treatment drugs. There has been current 
research to find other pharmaceutical and natural products that can aid in the prevention 
and reversal of insulin resistance. There have been many claims about the effects of 
insulin sensitivity from many natural sources that are worth looking into for potential 
therapeutic effects. 
1.2.8 Plant Secondary Metabolites 
 Primary plant metabolites are essential to plant growth, development and 
homeostasis and are ubiquitous in all plants. Primary metabolites include carbohydrates, 
lipids, proteins, chlorophyll and nucleic acids. In addition to these key roles in plants, 
some of these metabolites are pre-cursors to secondary metabolite synthesis. 
Phytochemicals are secondary plant metabolites that are variously distributed among the 




Phytochemicals are mainly synthesized from carbohydrates through the shikimate and 
phenylpropanoid pathways; however some secondary metabolites such as alkaloids are 
synthesized from amino acids. Most water soluble secondary metabolites (SM) can be 
found in the plant cytosol and vacuoles while most lipophilic compounds are found in 
the endoplasmic reticulum. SM synthesis can also be found in the chloroplasts (the 
alkaloid caffeine and the monoterpenes). Phytochemicals serve many purposes in plant 
tissues including protection from abiotic stresses, defense against herbivores, pathogens, 
and inter-plant competition, and attraction from beneficial organisms such as pollinators. 
Phytochemicals also exert beneficial effects through synergistic actions of several 
chemical compounds acting at target sites associated with a physiological process.59 In 
some ways phytochemicals could act for potential human health benefits include being 
an inhibitor, substrate or cofactor for some cellular enzymatic action, a ligand for cell 
surface receptors, or as scavengers for toxins or free radicals in the body.60 
 There are four major classes of phytochemicals: terpenoids, polyphenolics, 
alkaloids, and fiber. Terpenoids, also known as isoprenoids, are the largest group of 
plant secondary metabolites in green foods, soy plants and grains. The terpenoids class 
of compounds include monoterpenes such as limonene in citrus peel and menthol in 
peppermint, sesquiterpenoids and their lactones, diterpenoids including kahweol and 
cafestol in coffee beans, triterpenoids including limonoids, phytosterols such as β-
sitosterol and its glycoside, saponins and their derivatives, and carotenoids including 
carotene and xanthrophiles.61 Terpenes have some properties unique to other 




using photosensitizing pigments. Terpenes have a unique antioxidant activity mechanism 
when interacting with free radicals. Terpenes partition themselves into fatty membranes 
by their long carbon side chains. Carotenoids are extensively studied for their AOX 
activity and appear red, orange, and yellow in foods.60 
 Alkaloids are nitrogen containing compounds produced mainly from amino 
acids. Some alkaloid rich plants including many flowering and herbaceous plants found 
in Ranunculaceae, Rubiaceae, Papaveraceae, Fumariaceae, and Solanaceae families. The 
legume/bean family, Leguminosae, is known to have high alkaloid concentrations in the 
plants and roots. The rose family, Rosaceae, containing the large genus Prunus (plums, 
peaches, cherries, almonds etc.) is very low in alkaloids, as is the mint family 
(Graminaceae).62 Many alkaloid containing plants are toxic for human consumption in 
high concentrations. Some alkaloids found in small doses in foods include glucosinolates 
in cruciferous vegetables such as cabbage. Glucosinolates contain sulfur and nitrogen 
and are derived from amino acids and glucose. In plant cells, glucosinolates can 
transform into isothiocyanates and sulfuraphanes.  
 The SM class of fiber has the most publicity associated with it for its multiple 
health benefits in humans and functions in foods. Fiber is classified as plant material that 
is resistant to digestive enzymes that is neither degraded nor absorbed but pass through 
the upper GI into the large intestine. Fiber can be classified as insoluble or soluble. 
Insoluble fiber is found in mostly cereals and legumes. It is slowly and incompletely 
fermented by the colon and has a pronounced effect on bowel habit. Typical plant 




found in fruits and vegetables and undergoes colonic degradation. It has high ferment 
ability and is also known to slow glucose absorption. Some sources of soluble fiber 
include pectin, β-glucans, arabinoxylans, and galactomannans.63An important function 
that fiber has in T2DM high risk individuals is protection by increasing fecal bulk, which 
dilutes the increased colonic bile acid concentration that occurs with a chronic high fat 
diet (HFD).  
 Lastly, the polyphenolic SMs are an integral part of the human diet. They are 
produced mainly through the shikimic pathway in plants, and malonic acid pathways in 
fungi and bacteria. The shikimic pathway begins with carbohydrate intermediates from 
the pentose phosphate pathway which is used to form phenylalanine (F) and tyrosine 
amino acids. Phenylalanine ammonia lyase will transform F into cinnamic acid for 
benzoic acid derivatives, and transformation into p-coumaric acid which forms caffeic 
acids and other simple phenylpropanoids and coumarins. Synthesis can continue to 
produce chalcones, flavonones, flavones, isoflavones, flavonols, anthocyanins and 
tannins. Flavonoids are the largest class of phenolic compounds in plants. Ring A on the 
flavonoid skeleton is derived from the acetic acid (via acetyl CoA) and malonic 
pathways, while ring B is a product of the shikimic pathway.61  Some major phenolic 
compounds found in plants include hydroxybenzoic and hydroxycinnamic acids, 







1.2.9 Polyphenolic Compounds 
 There are over 8000 phenolic compounds currently described from the literature 
ranging from a simple one carbon ring phenolic acid structure to very complex 
procyanidin dimer and trimer structures. Phenolic compounds are categorized by their 
chemical structure, with all phenolics containing a benzene ring and one hydroxyl group 
(Figure 1). More often in nature, phenols will be attached to a sugar moiety or an organic 




Figure 1. Phenolic compound backbone structure. Phenolic compounds are classified by 
their chemical composition of containing one or more phenol structures (at least one 




 Flavonoids are the largest class of phenolic compounds in plants and are known 
for their contribution to the quality of some fruit’s color, aroma and texture. Flavonoids 
are found in high concentrations in the epidermis of leaves and skin of fruits. Flavonoids 
are consumed frequently by humans and are found ubiquitously in fruits, vegetables, tea, 




atoms arranged in a C6-C3-C6 skeleton (Figure 2). Hydroxyl groups are usually found on 
the 4’, 5 and 7 positions. In nature, flavonoids exist as glycosides. The major flavonoid 
subclasses are flavonols, flavones, flavan-3-ols, anthocyanidins, flavanones and 
isoflavones. Minor flavonoids (from a dietary perspective) include the flavan-3,4-diols, 




Figure 2. Basic flavonoid skeleton backbone (C6-C3-C6). Flavonoids contain a 15 carbon 




 The flavonols are the most widespread of all the flavonoids with over 200 
aglycones reported. The most commonly found flavonols include kaempferol, quercetin, 
myricetin, and isohamnetin. These mainly occur as O-glycosides in the outer tissues of 
plants as their synthesis is stimulated by sunlight. Flavonol bioavailability to humans 




are not widely dispersed in nature. The only sources in plants are in parsley, celery, and 
a few herbs. There are some reports of polymethoxylated flavones in citrus fruits, such 
as tangeretin and nobiletin. Flavones occur as 7-O-glycosides. Flavan-3-ols (flavanols) 
are complex flavonoids that range in structure of monomers of (+) catechin and (-) 
epicatechin to polymeric and ogliomeric proanthocyanidins (condensed tannins). In 
plants, common proanthocyanidins can have up to 50 monomer units and are primarily 
made up of epicatechin (procyanidins). Not so common proanthocyanidins include those 
made up of (-) epiafzelechin, (+) afzelechin, and epi-gallocatechin (EGC), namely 
propelargonidins and prodelphinidins. Catechins are widespread in nature, with most 
dietary sources coming from tea, wine and chocolate. Flavan-3-ols are easily 
transformed with food processing, as seen with the fermentation of green tea catechins to 
black tea theaflavins, theacitrins, and thearubigins.65 
 Anthocyanins are ubiquitous in nature, mostly occurring in fruits and flower 
tissues. Main sources of anthocyanins in the diet are from the families Vitaceae (grapes) 
and Rosaceae (cherry plum raspberry strawberry blackberry apple peach etc.) other 
families include Solanaceae (tamarillo and eggplant), Saxifragaceae (red and black 
currants), Cruciferae (red cabbage) and Ericaceae (blueberry and cranberry). 
Anthocyanins are responsible for the red, blue and purple pigments that attract 
pollinators to the plants. Anthocyanins are also found in leaves, stems, seeds and root 
tissues and protect plants from excessive light by shading leaf mesophyll cells.65In fruits, 
anthocyanin concentration will usually increase with plant ripening. Anthocyanin 




commonly found), delphinidin, peonidin, pelargonidin, petunidin, and malvidin. These 
compounds are monoglycosylated at position 3 on the O-glycosidic bond with glucose, 
arabinose, and galactose. Cyanidin glucosides are the most common anthocyanins in 
fruits. Anthocyanins can also be chemically bonded to acids (acylated anthocyanins) as 
in the case of some grape species.6The flavanones are present in high concentrations in 
citrus fruits with the most common flavanones glycoside being hesperetin-3-O-
rutinoside (hesperidin) which is found in citrus peels along with narirutin. These 
flavanones rutinosides are tasteless, while their conjugates neohesperidin (bitter orange) 
and naringin (grapefruit peel) are intensely bitter.65 Isoflavones are found mainly in 
leguminous plants with the highest concentrations coming from soybean. Isoflavones, 
although are classified as flavonoids, are also sometimes known as phytoestrogens 
because of their estrogenic activity, mainly daidzein, genistein, coumestrol and 
coumestan.66 
 Non-flavonoid compounds are, by definition, all other phenolic compounds that 
do not have the flavonoid skeleton backbone. This category includes simple phenols 
such as volatiles like eugenol from cloves, 4-vinylguaiacolin from coffee roasting, and 
tyrosol and hydroxytyrosol in virgin olive oil, the phenolic acids including 
hydroxybenzoic acids and hydroxycinnamic acids, hydrolysable tannins, acetophenones, 
phenylacetic acids, coumarins, benzophenones, xanthones, stilbenes, chalcones and 
secoiridoids, such as oleuopein, the bitter principle in black olives.67 The main difference 
in the phenolic acid classifications is that hydroxybenzoic acids contain (C6-C1) 




The most common hydroxybenzoic acid in food is gallic acid, found mostly in an ester 
bond to sugar compounds. All hydroxybenzoic acids are derived directly from benzoic 
acid. Hydroxycinnamic acids are derived from cinnamic acid and are present as caffeic 
acid, ferulic acid, p-coumaric acid and their conjugates with caffeic acid being the most 
ubiquitous in fruits and ferulic acid being the most common in cereal grains.65 
Hydroxycinnamic acids are found in all parts of fruits, with the highest concentrations in 
the outer parts but decrease in abundance upon ripening. Usually, these phenolics are 
rarely found as free acids but rather are ester-bonded between the carboxylic acid group 
of the phenolic and a hydroxyl group of an organic compound such as quinic acid, as in 
chlorogenic acids. Coumarins and lactones are mainly derived from o-hydroxycinnamic 
acids by cyclization. The main coumarins in foods are found as essential oils in foodstuff 




Figure 3. Structural differences between phenolic acid backbones. 





 Benzophenones are scarce in foods and xanthones are only found in mango and 
mangosteen. Of the other non-flavonoid groups, some commonly known compounds 
include the stilbene resveratrol and the chalcones naringenin and phloridzin. While these 
compounds can be found in all foods, some compounds have a high concentration in 
specific plants. In cereal grain products higher concentrations of flavonoids, phenolic 
acids, and tannins are present. Legumes contain isoflavonones and vegetables hold 
mainly flavonoid glycosides. Most roots and tubers hold low concentration of 
flavonoids. Apples and citrus fruits are dominated by phenolic acids and flavonoids, 
while berries show high anthocyanin content.68  
1.2.10 Bioavailability 
 It is estimated that around 25mg-1g of phenolic compounds are consumed 
regularly in the diet, with around 50mg–800mg per day from flavonoid sources. 
Phenolics are transformed before absorption which determines the biological activity of 
the compounds. The gut bacteria can hydrolyze these compounds, and depending on 
their structure, this may enhance or decrease availability. Gut bacteria can hydrolyze 
glycosides, glucuronides, sulfates, amides, esters, and lactones. Glycoside hydrolysis 
leads to more biologically active compounds, while aglycone hydrolysis leads to more or 
less active compounds depending on the original substrate and the resulting product.69 
Anthocyanins are consumed in varying concentration in the diet, from 12.5mg/day up to 
200mg/day with regular intake of fruits and berries but studies have shown low 
availability in the body with no outstanding evidence of post absorption or metabolism 




Procatechuric acid may be an oxidative degradation product from cyanidin-3-glucoside 
consumption, but there are few studies on anthocyanin digestion and absorption. The 
anthocyanin aglycone is based on the flavilium ion (2-phenylbenzopyrilium). The 
chemically unstable aglycone converted to phenolic acids, for further metabolism by 
micro flora. Procatechuric acid (3,4-dihydroxybenzoic acid) is the main end product. 
Other metabolites produced by bacteria from anthocyanins include syrinic acid (3,5-
dimethoxy-4-hydroxybenzoic acid), vanillic acid (3-methoxy-4-hydroxybenzoic acid), 
phloroglucinol aldehyde (2,4,6-trihydroxybenzaldehyde), phloroglucinol acid (2,4,6-
trihydroxybenzoic acid) gallic acid (3,4,5-trihydroxybenzoic acid) and 3-O-methylgallic 
acid, depending on the original composition. Other metabolites that are not converted 
into phenolic acids are unknown in structure.69 
 Flavonols such as quercetin have a low concentration in the diet (about 20-50mg 
per day) but their bioavailability has been extensively studied.71 Flavonols are 
extensively degraded by colonic bacteria. Quercetin metabolites depend on the 
hydroxylation pattern of the B ring and includes 2-(3,4-dihydroxyphenyl)acetic acid, 2-
(3-hydroxyphenyl)acetic acid, and 3,4-dihydroxybenzoic acid from the B ring and 
phloroglucinol, 3- (3, 4 dihydroxyphenyl) propionic acid and 3- (3-hydroxyphenyl) 
propionic acid from the A ring. There have also been reports of 3,4-
dihydroxybenzaldehyde, 2,4,6-trihydroxybenzoic acid, 2-(3,4-dihydroxyphenyl) ethanol, 
3-(3,4-dihydroxyphenyl) benzoic acid methyl ester, 3-methoxy-4-hydroxybenzoic acid 
(vanillic acid), and 3-(m or p-hydroxyphenyl) propionic acid metabolites. Flavanones, 




are more bioavailable than other flavonoid groups as they are less degraded by colon 
bacteria so more available for absorption.69  
 For hydroxycinnamates a general trend is that from esters, the free acid is 
released by bacterial esterases, and the free acid is then metabolized to reduce the double 
bond to give rise to phenylpropionic acid and, then, decarboxylated to produce 
phenylacetic acids. After the ingestion of chlorogenic acids they are hydrolyzed in the 
gastrointestinal tract by cytosolic esterase in the gut micro flora. Once broken down 
available caffeic acid metabolites are absorbed into the vascular system.72It has been 
reported that approximately 33% of ingested chlorogenic acids are absorbed, and 95% of 
ingested caffeic acids are absorbed. The main microbial metabolites of caffeic acid are 
3-hydroxyphenylpropionic acid and benzoic acid. Both metabolites are also obtained 
from chlorogenic and caftaric acid, suggesting that the esterification has no influence on 
the metabolism of caffeic acid by the gut Microbiota.69 Hydrolysable tannins including 
gallotannins and ellagitannins are hydrolyzed to yield glucose and gallic acid 
(ellagitannins undergo lactonization to produce gallic acid) While studies from 
condensed tannins (oligomeric and polymeric procyanidins) show benzoic, phenylacetic, 
phenylpropionic, and phenyllactic acid derivatives produced. Polymeric procyanidins are 
not absorbed, however, and pass unaltered into the large intestine where colonic bacteria 
break down the polymer into phenolic acids that get absorbed into the circulatory system 
and get excreted into urine.7 However, epicatechin and catechins are extensively 
metabolized and are conjugated during transfer from the gut lumen to the serosal 




tissues may be responsible for some reports of low plasma concentrations in some 
studies. Any phenolic being ingested must be cleaved of any glycosides before 
absorption in the colon. The remaining aglycone is absorbed through the epithelium and 
is conjugated with glucuronic acid or sulfate in the lumen. When 50mg of aglycone is 
ingested, approx. 0.4µmol/L plasma metabolites will be measured71. Main metabolite 
after intake in urine from catechin and epicatechin are 3-(3-hydroxyphenyl) propionic 
acid, 5-(3’,4’-dihydroxyphenyl)-y-valerolactone, 5-(3’-hydroxyphenyl)-y-valerolactone, 
and 3-hydroxyhippuric acid. 
1.2.11 Phenolics in Insulin Resistance 
 In the metabolic syndrome and T2DM, some studies on the effect of natural 
compounds in vivo, in vitro, and clinical trials have been performed with phenolic 
compounds showing promising results. Flavonoid antioxidants (AOX) have shown 
inhibition of reactive oxygen species (ROS) production by inhibiting ROS producing 
enzymes and quercetin has been shown to regulate the gene expression of the pro-
inflammatory cytokine, nuclear factor kappa beta (NFkβ).73 Also, dietary AOX have 
shown the ability to protect pancreatic β-cells from glucose induced oxidative stress. 
Anthocyanins are free radical scavengers that increase serum AOX levels after 
consumption. Anthocyanins were able to decrease high fat diet induced obesity in 
vitro.74In human studies of chokeberry consumption (high anthocyanin content) fasting 
glucose and serum triglyceride levels of T2DM patients were significantly decreased.75 
Canadian low-bush berry (high anthocyanin content) has been able to illicit an increase 




delphinidin glycosides may increase insulin secretion in pancreatic β-cells.76 Oligomers 
of grape seed procyanidin extracts (GSPE) activate the insulin receptor and key targets 
of the insulin signaling pathway by activating protein kinase B at Thr308 however at a 
weaker signal than insulin does, according to the lower insulin receptor activation by 
procyanidins. On the other hand, they phosphorylate AKT at Ser473 to the same extent 
as insulin. GSPE also decrease hyperglycemia in diabetic rats and stimulate glucose 
uptake insulin sensitive cells.77In a double blind clinical study, obese, non-diabetic and 
insulin resistant men and women were put on a diet supplementation with blueberry 
bioactives to determine their in vivo effects on insulin sensitivity. The study concluded 
the blueberry bioactives group enhanced insulin sensitivity without significant changes 
in overall adiposity, energy intake and inflammatory biomarkers in the participants.78 
Caffeic acid was shown to increase glucose utilization and glucose uptake in 
streptozotocin induced and insulin resistant models of rats.79 Flavonoids and phenolic 
acids are able to inhibit adipogenesis in 3T3-L1 adipocytes with o-coumaric acid and 
rutin giving high inhibition of intracellular triglyceride accumulation and on GPDH 
activity and inhibited PPARγ, C/EBPα and leptin as well as up regulate adiponectin.80 
Caffeic, chlorogenic, and ferulic acids were able to lower glucose production via 
gluconeogenesis and glycogenesis compared to metformin via in vitro rat hepatoma 
cells.81 Ethyl acetate fractions of rice bran high in ferulic acid as well as a ferulic acid 
standard were able to decrease blood glucose levels and increase plasma insulin levels in 
type II diabetic mice.82 In an in vitro study on L6 muscle cells, chlorogenic acid was 




dependent pathway.83 Finally, dried plums were tested on insulin resistant and obese 
Wistar fatty rats and were found to significantly increase plasma adiponectin 
concentrations and PPARγ mRNA expression in the adipose tissue as well as decrease 
blood glucose and plasma triglyceride concentrations.84  
1.2.12 Stone Fruit Prunus Persica (L.) Batsch 
 Stone fruits (drupes) refer to fruits that develop around a hardened stone center 
(pit) that is derived from the ovarian wall of the plant. These fruits belong in the family 
Rosaceae under the genus Prunus which includes the fruits of peach, plum, nectarine, 
cherry, and apricot as their inner pit is large and extremely hard. The fruit crops provide 
prime fruit from June through September. As these fruits are native to warm climates 
one main issue of concern of for consumption is chilling injuries due to low 
temperatures.  
 Peaches (Prunus persica) are one species of the Prunus genus that originated 
from China and migrated all over the world with main growing sites in Europe (Spain 
and Greece) the US (California) and South America (Argentina and Chile). The peach 
falls under the kingdom Plantae (plants); subkingdom Tracheobionta (vascular plants); 
superdivision Spermatophyta (seed plants); division Magnoliophyta (flowering plants); 
class Magnoliopsida (Dicotyledons); subclass Rosidae; order Rosales; family Rosaceae 
(rose family); genus Prunus species Prunus persica (L.) Batsch (peach); with two 
taxonomy varieties: Prunus persica (L.) Batsch var. persica (peaches) and Prunus 




 Other than the accepted taxonomy order, there are endless ways to categorize 
peaches being used currently. Peaches are categorized by their fruit shape (round, flat), 
texture (melting, non-melting, stony hard), flesh adherence to pit (freestone, clingstone), 
flesh color (white, yellow), flesh acidity (acidic, low acidic), or commercial fruit type: 
peach (pubescent skin), nectarine (glaborous skin), and canning peach (non-melting 
flesh).86 The white and yellow flesh peaches are popular for commercial consumption, 
with the white having a unique flavor and aroma and yellow able to mask oxidation from 
bruising and blemishes. Peaches have a soft flesh and are highly perishable 
commodities. They are composed of approx. 90% water and contain carbohydrates, 
vitamins, volatiles, antioxidants and trace amounts of proteins and lipids. Immature 
peaches have little to no starch grains, and with maturation these get converted into 
soluble sugars. Peach total weight is comprised of around 7-18% of soluble sugars and 
around 0.3% of fiber. Sucrose is the most predominant sugar found in peaches (40-60%), 
followed by glucose and fructose which when all combined account for 75% of the 
peach’s soluble sugars. There has also been trace amounts of sorbitol found in peaches 
as well. Low quality peaches may report higher fructose and sorbitol values, however.86 
 The flavor of peach flesh comes from the fruit’s aromatic volatiles, organic acids, 
phenolics, and sugars. The main volatiles in peaches to add to its flavor include hexanol, 
trans-2-hexanol, linalool, and decalactones while the main organic acids present are 
malic (>50%), citric, quinic, and succinic acids. Vitamin C (ascorbic acid) is typically 
low in most fruit cultivars (<10mg in 100g fresh weight), and Pro-Vitamin A 




pigments from xanthophylls that are synthesized by hydroxylation from carotenoids, 
specifically lutein, zeaxanthin, antheraxanthin, and violaxanthin from β-carotene. 
Carotenoids in peaches are photosynthetically active, while xanthophylls dissipate light 
that can disrupt photosynthesis. Both of these compounds can be found in the 
chloroplasts of the cells.86 Phenolics in peaches can affect the overall flavor by giving 
astringent off flavors when are found in high concentrations. Exposed phenolics also 
undergo reactions by polyphenol oxidase (PPO) enzymes that create quinone browning 
products, also negatively affecting the fruit.  
 The polyphenolic compounds that are found in varying peach varieties include 
hydroxycinnamic acids, anthocyanidins, procyanidins, and flavonol derivatives. 
Specifically, of a research paper characterizing phenolics in different varieties of 
peaches, as well as plums and nectarines, the predominant phenolics found in the flesh 
and skin of these fruits were 3-caffeoylquinic acid (chlorogenic acid), 5-caffeoylquinic 
acid (neo-chlorogenic acid), procyanidin dimers and trimers, quercetin derivatives and 
cyanidin conjugates as glycosides, galactosides, rutinosides, and acetyl-glycosides. Only 
cyanidin-3-O-glucosides were found in peach varieties.7 Anthocyanins such as cyanidin-
3-O-glucoside are responsible for the production of a red color from the vacuoles of the 
peach and interestingly, the anthocyanin content in peaches usually occurs in the skin 
and the flesh nearest to the pit of the fruit. The anthocyanin content is independent of 
cultivar variety flesh color (yellow or white) and in some part, is dependent on light 





 The main objectives of this thesis are to identify peach, plum, and nectarine 
phenolic compounds in cultivars of Rich Lady, Black Splendor, and Spring Bright, 
develop an insulin resistant murine skeletal muscle model, and view the effects of the 
stone fruit on G6P production in the cells. The next objective was to isolate the four 
major phenolic classes of compound by reverse phase silica cartridge while eliminating 
unwanted fruit material from original extracts and to identify those compounds. The 
second was to determine the yield recovery of those phenolic fractions after separation 
with the silica to determine the feasibility of the method. The last was to test the 
phenolic fractions on a cell model of insulin resistance; to determine if there is any 
positive biological effect on insulin sensitivity. Lastly, the conclusions to the findings of 





2. PEACH, PLUM AND NECTARINE EXTRACTS SCREENING EFFECTIVENESS 
ON MYOTUBULAR INSULIN RESISTANCE 
 
2.1 Overview 
 Stone fruit cultivars contain a mixture of diverse secondary metabolites in their 
flesh and peels, including polyphenolic compounds. Previous research has identified 
phenolic compounds, carotenoids, and vitamin C content as well as macronutrient 
composition on various stone fruit cultivars. Peach, plum, and nectarine cultivars show 
to have hydroxycinnamic acids, anthocyanin, flavonols, and catechins present in their 
flesh and peels7. These compounds of hydroxycinnamates, anthocyanins, procyanidin 
polymers, and other flavonoids have been reported in the literature to have positive 
effects against insulin resistance, type II diabetes mellitus (T2DM), and other symptoms 
of the metabolic syndrome.8-9, 73-84 A major player in cellular tissue insulin resistance is 
skeletal muscle; with a majority of the blood glucose from food entering into the muscle 
and being converted to glycogen storage for future energy usage. Skeletal muscle is the 
second main source of glycogen storage behind the liver tissue. From Rich Lady peach, 
Black Splendor Plum, and Spring Bright nectarine the HPLC phenolic profiles were 
found and fruits were used as potential treatments in palmitic acid induced insulin 
resistant C2C12 myotubes. The fruit’s effectiveness was analyzed by the results of 
insulin stimulated intracellular G6P production.  Extracts were purified from sugars and 
organic acids by SPE reverse phase C18 silica gel and freeze-dried. Extracts used in cells 




concentration in the cells was 0.5%. Extracts were tested at levels of 0 – 300 µg/mL for 
cytotoxicity testing, and were used at levels of 0, 10, and 100 µg/mL for glucose 6-
phosphate assay. Myoblasts were fully differentiated into mature myotubes and exposed 
to palmitic acid (0.5mM) for 48hr to induce insulin resistance and then treated with fruit 
extracts for 16hr and stimulated with insulin (100nM) for 30 minutes. Peach and 
nectarine showed to have a significant effect on glucose 6-phosphate accumulation in the 
cells at 1 and 10 µg/mL, respectively, while plum extracts showed no significant effects 
on the cells as compared to the positive control, metformin, a known diabetic, insulin 
sensitizing drug. 
2.2 Introduction 
 There has been recent interest in stone fruits, along with other fruits, for their 
potential health benefits from certain diseases. For example, Black Splendor plum and 
Rich Lady peach were tested for their chemo preventative potential against breast cancer 
in vitro.87 Stone fruit phenolics have shown similar phenolic flavonoids as apples, but 
also provide anthocyanin compounds (mostly in the skin) as in various berries. Stone 
fruit phenolics consist of mainly hydroxycinnamates, procyanidin dimers, flavonols, and 
anthocyanins. Specifically, of 25 varieties of peaches, plums, and nectarines, the 
predominant phenolics found in the flesh and skin were 5-caffeoylquinic acid (neo-
chlorogenic acid), 3-caffeoylquinic acid (chlorogenic acid), procyanidin dimers and 
trimers, quercetin derivatives and cyanidin conjugates as glycosides, galactosides, 
rutinosides, and acetyl-glycosides. Only cyanidin-3-O-glucosides were found in peach 




acetyl-glycosides.7As mentioned previously, there has been literature study on these 
compounds as potential insulin sensitizers in clinical and animal studies as well as cell 
studies. While literature has shown individual compounds as well as some whole 
extracts of the same group of compounds having beneficial affects against insulin 
resistance, few papers report fruit extract of these compounds effect on insulin resistance 
specifically in muscle tissue. The main uptake and storage of insulin-stimulated glucose 
occurs in the liver and muscle tissues. As muscle cells present a simple mechanistic 
pathway from glucose uptake to glycogen storage, it makes this model more suitable for 
this experiment. While glucose uptake and glycogen storage is also important in liver 
tissues, there are more complex pathways to consider when looking into insulin 
sensitivity and resistance, while muscle cells function regarding glucose uptake uses 
mainly insulin stimulated pathways that are more easily tracked and explained through 
biomarkers. G6P was chosen as the biomarker of interest because the G6P level is 
directly related to the amount of glucose uptake into the muscle cells, with an increase of 
insulin stimulated glucose uptake into the cell, there is a direct increase in G6P 
intracellular concentration. Unlike the liver, muscle cells contain no G6Pase so it is safe 
to assume a direct increase in insulin stimulation and sensitivity with a G6P increase in 
muscle cells. The objectives of this chapter were to extract peach, plum, and nectarine 
phenolic fractions without significant organic acids or sugars and to test their bioactive 
potential against a developed insulin resistant muscle cell model, specifically the 





2.3 Materials and Methods 
2.3.1 Plant Material 
  Commercial varieties of Black Splendor plum, Rich Lady peach and Spring 
Bright nectarine were grown in California and collected at a mature stage and stored at 
2-4oC. Upon arrival at Texas A&M University, the fruits were frozen after removal of 
the pits and kept at -80oC until use. 
2.3.2 Extraction and Purification  
 60 grams of fruit with proportional distributions from flesh and skin in the form 
of slices was blended with 180ml of 100% methanol (ultra-turrax (IKA. Works, Inc., 
Wilmington, NC)) and left at 4oC overnight. Extracts were filtered through 4 layers of 
cheesecloth and then centrifuged at 15000 RPM for 15 minutes at 4oC. Supernatants 
were collected and methanol was evaporated at 45oC using a rotavapor (Buchi, 
Switzerland). The remaining aqueous extracts were reconstituted in distilled water to 
original volume (180ml) and purified of sugars and organic acids through solid phase 
extraction using a SEP Pack C18 cartridge as reported by Noratto et al.87 Briefly, the 
aqueous extracts were adjusted to pH 7.0 with 5 N NaOH. A repeated batch system of 
20mL of aqueous extract was loaded in a SEP Pack C18 cartridge (9 cartridges) (55-105 
μm, Waters Corp., Milford, MA) previously conditioned to pH 7.0 with 200mLof 100% 
methanol and 200mLof nanopure water (pH7.0). The sugars and some phenolic acids 
were not retained on the cartridges. The cartridges were washed with 100ml water (pH 
7.0) per batch. The water from the wash was combined with the phenolics that were not 




to pH 2.0 with 0.01% triflouro-acetic acid (TFA). This mixture was loaded into a second 
cartridge previously conditioned at pH 2.0 with 200mL of 100% methanol and 200 mL 
of nanopure water at pH 2.0. The cartridge was washed with 100 mL of water (pH 7.0) 
per batch where sugars and organic acids were released from the C18. The remaining 
compounds were eluted with 100ml of 100% Methanol (pH 7). The remaining 
compounds on the first C18 cartridge were eluted with 100ml per batch each of 16% 
Acetonitrile adjusted to(pH 2 ) with 0.01% TFA, Ethyl Acetate, and 100% methanol to 
improve recovery of all compounds with polarity and pH differences. All solutions from 
all batches were combined (2.8L) and solvent evaporated at 45oC using the rotavapor 
(Buchii, Switzerland) using a large volume (400ml) sample flask. Samples were 
evaporated in a batch system until low volume (10ml) from the large sample flask and 
collected into a smaller sample flask. The small sample (100ml) flask containing the 
condensed aqueous remains (70ml) were evaporated until only water remained (10-
20ml), frozen at – 80oC and freeze-dried (FTS Systems, INC. Stone Ridge, NY) at -50oC 
and 200 mg HG of pressure until a powder. The clean powders were stored at -20oC until 
use. 
2.3.3 Total Soluble Phenolics 
 Peach, plum, and nectarine freeze dried powders were weighed after 
lyophilization and tested for their amounts of total soluble phenolics by the Folin-
Ciocalteau method adapted by Swain & Hillis.88 Peach, plum, and nectarine freeze-dried 
powders (4.5mg) were diluted in 1ml of methanol (Sigma, St Louis, MO). 15 µl of 




water in a 96 well microplate and reacted with 0.25N Folin-Ciocalteau reagent (15µl) for 
3 minutes and then 1N Na2CO3 (30µl) for two hours before reading the 
spectrophotometric value at 725nm. Sample amount of total phenolics were determined 
from the standard curve developed. Total soluble phenolics were expressed as mg 
chlorogenic acid equivalents (CAE)/g freeze dried sample. 
2.3.4 Thin Layer Chromatography of Stone Fruit Phenolics  
 All TLC assays were done as reported or adapted from Wagner et al.89 except 
carbohydrate detection reported from Toba and Adach. 90 All TLC assays were run on 
silica gel 60F254 pre coated plates (Merck, Darmstadt). Powdered stone fruit samples 
were solubilized in methanol as a 3% solution (w/w) and 10µl solutions were used for 
plating. 5-10µl of reference solutions were used for plating. For phenolic detection an 
ethyl acetate: formic acid: glacial acetic acid: water (100:11:11:26) mobile phase was 
used. Plates were sprayed with natural products reagent (NP/PEG) and fluorescence was 
observed under UV-365. Reference solutions of chlorogenic acid, quercitin and rutin 
were prepared as 0.05% solutions in methanol. For carbohydrate detection a propanol: 
water (85:15) mobile phase was used. Plates were sprayed with DAAP reagent and the 
plate heated to 80oC for 5 minutes. Sugars observed visibly. Reference solutions of D-
glucose, sucrose, L-rhamnose, and D-galactose were used. For sterol determination a 
hexane: ethyl acetate (1:1) mobile phase was used. Plates were sprayed with 
Liebermann’s reagent and heated to 110oC for 10 minutes and viewed under UV 365 
nm. A reference solution of b-sistosterol in chloroform was used. For coumarin 




ethanolic KOH and viewed under UV 365nm. A reference solution of Angelica Root 
(Dang Gue Wei) in methanol was used. For terpene detection an n-butanol: ethyl acetate: 
ammonia: water (60:40:1:10) mobile phase was used. Plates were sprayed with an 
anisaldehylde: sulfuric acid reagent and heated to 100oC for 10 minutes then observed 
UV 365nm. A reference solution of C. Asiatica extract was used. For saponin detection a 
chloroform: methanol: water (64:50:10) mobile phase was used. The plates were sprayed 
with Vanillin-Sulfuric Acid reagent and heated to 110oC for 10 minutes and observed 
visibly. A reference solution of Quillaja saponaria (molina) extract was used. For 
anthocyanin detection an n-butanol: glacial acetic acid: water (40:10:20) mobile phase 
was used. Plates were observed vis. Reference solutions of cyanidin 3-glucoside; 
delphinidin chloride, leutonin chloride, and pelargonidin chloride were used. For Arbutin 
detection an ethyl acetate: formic acid: water (88:6:6) mobile phase was used. Plates 
were sprayed with 5% ethanolic KOH and observed visibly. A reference solution of 
hydroquinone was used. 
2.3.5 HPLC Analysis of Stone Fruit Phenolic Profiles 
 Chromatographic separations were performed on a High-Performance Liquid 
Chromatography-Diode Array Detection (HPLC-DAD). The HPLC system was 
composed of two 515 binary pumps, a 717-plus auto-sampler, and a 996-photodiode 
array detector (Waters Corp., Mildford, MA). Phenolic compounds were separated on a 
4.6mm×150 mm, 5 μm, C18 reverse-phase Atlantis column (Waters Corp.) that was 
maintained at 25℃ by a Spectra-Physics SP8792 column heater. The mobile phases 




1 mL/min. Separations were achieved by a linear gradient with A and B: 0 min 85% A, 5 
min 85% A, 30 min 0% A, 35 min 0% A. The injection volume was 10 μl. Data were 
processed with the Millennium software v3.1. The identification of individual phenolics 
was based on their UV spectra, ESI fragmentation patterns from previous work, and 
retention time.  The identification was performed by HPLC using 3.0 mg powder 
dissolved in 1200uL 100% DMSO and filtered with a 0.22 μm nylon filter. 20 μl of 
filtered sample solution was injected to the chromatograph system. HPLC conditions 
used are those described above. 
2.3.6 Biological Material 
 The following chemicals were used in the experiments: palmitic acid, insulin, 
1,1-Dimethylbiguanide hydrochloride (metformin), Low Sugar-Dulbecco’s Modified 
Eagle’s Medium (DMEM), penicillin/streptomicyn mixture, trypsin EDTA, DMSO, 
BSA and Fetal Bovine Serum (FBS) were purchased from Sigma (St. Louis, MO), 
glucose from Acros Organics (Fair Lawn, NJ) and sodium bicarbonate from 
Mallinckrodt Chemicals (Phillipsburg, NJ). Murine C2C12 myoblasts were acquired 
from the American Type Culture Collection (ATCC) (Manassas, VA). 
2.3.7 Cell Viability Assay 
 Cytotoxic effects of extracts from peach, plum and nectarine were evaluated in 
C2C12 muscle cells using the MTS assay (Promega Corp., Madison, WI), according to 
the manufacturer’s instructions. The quantity of formazan product was measured at 490 
nm and is directly proportional to the number of living cells in culture. The assay was 




with Low sugar DMEM/10% FBS medium for 24 h before starting the treatments with 
the stone fruits extracts. Previously to their use, extracts from peach, plum and nectarine 
were diluted in 100% DMSO. The concentrations used were in the range of 0 to 300 μg 
dry freeze dried powder weight/mL, and the cell viability was measured after 24 h of 
exposure to the extracts. The final percentage of DMSO per well was 0.5%. 
2.3.8 Generation of an Insulin Resistant Cell Model and Treatment with Stone Fruit 
Extracts  
 C2C12 cells were seeded at a density of 120,000 cells/well in 6-well plates and 
cultured with Low sugar DMEM/10% FBS medium until they reached around 70% 
confluent. Low sugar DMEM/10% FBS was replaced every 2-3 days. Once the cells 
were confluent, they were cultured with low sugar DMEM/10% Horse serum medium 
during four days, to induce myoblast formation. To the myoblast, 0.5 mM palmitic acid 
in serum free 2% BSA low sugar DMEM media was added for 48 h to induce insulin-
resistance. After exposure to palmitic acid, the culture medium was replaced with fresh 
serum free-2% BSA-Low sugar-DMEM medium, and the extracts from peach, plum and 
nectarine were added separately in concentrations of 0, 1, 10 and 100 μg/mL, and co-
incubated in presence of 0.5 mM palmitic acid for 16 h. DMSO was added to control 
cells until 0.5%. 2.0 mM of 1,1-Dimethylbiguanide hydrochloride (metformin) was used 
as a positive control. After the treatments with stone fruit extracts, metformin and 
palmitic acid, the cells were exposed to 100 nM of insulin for 30 min, and cell samples 
were recovered on ice using G6P assay buffer from PicoProbe™ Glucose-6-phosphate 




chloroacetic acid (2N TCA) as enzymes in the cells can consume G6P and manufacture 
suggests deproteinizing samples; all the samples were centrifuged at 14,000 g for 2 min. 
After centrifugation, supernatants were recovered and the pH was neutralized with 1N 
NaOH until pH 6.5 – 7.5 for assay measurement conditions. 
2.3.9 Intracellular Glucose 6-Phosphate Quantification in C2C12 Muscle Cells  
 Cells were cultured and treated with palmitic acid and stone fruit extracts under 
the conditions described above. To measure the intracellular amount of Glucose-6-
phosphate, the PicoProbe™ Glucose-6-phosphate assay kit (BioVision. Catalog #K687-
100) was used, following the manufacturer’s instructions. Briefly, neutral pH samples 
were placed in duplicated in a 96-well plate (black body, clear bottom, COSTAR) and 
incubated at 37°C, protected from light, with the reaction mix for 30 min. A glucose-6-
phosphate standard curve was measured together with the samples, under the same 
conditions. Once the incubation time was over, the amount of glucose-6-phosphate was 
measured by a fluorescence in a microplate reader at Ex/Em = 485/560. Data was 
calculated according the manufacturer’s instructions. 
2.3.10 Statistical Analysis 
 The data were analyzed using one-way analysis of variance (ANOVA) followed 
by Turkey-Kramer HSD test, using the software JMP v9.0. Results are expressed as 
means ± standard deviations (S.D) of at least 3 replicates. Different letters denotes 






2.4 Results and Discussion 
2.4.1 Analysis of Yield Recovery of Total Soluble Phenolics from Freeze-Dried Peach, 
Plum, and Nectarine Powder Extracts  
 Total soluble phenolics were quantified in the freeze dried fruit extracts as well 
as the methanol extracts. The methanol fruit extract total soluble phenolics in plums was 
0.64 mg CAE/ml, while peach methanol extract phenolics was 0.123 mg CAE/ml, and 
nectarine methanol extract phenolic content was 0.06mg CAE/ml. From the 
lyophilization process, 392 mg of powder was collected from plum, 499 mg collected 
from peach, and 221 mg collected from nectarine. Of this powder quantified, the fruit 
mg CAE/ml was determined, and by extension of weight, the total amount of phenolics 
standardized by chlorogenic acid was found in the total powder. Each fruit freeze dried 
powder came from 60g of raw fruit. The final amounts are represented in table 1. Folin 
results show that the amount of chlorogenic acid equivalent phenolics in the powder is 
much less than the total powder weight, specifically, 6.3% for plum, 1.2% for peach, and 
1.4% for nectarine. However, HPLC and TLC analysis confirm that the phenolic 
compounds are the main category of compounds found in the freeze-dried powders and 
possibly the rest of the powder weight come from a carbohydrate source. This reported 
data implies that the phenolic concentrations at work in the cells are at a much lower 
































Plum 3.2 0.64 63.49 + 0.18 
 
0.3919 6.3 16.2 
Peach 0.62 0.12 11.83 + 0.10 
 
0.4986 1.2 20.5 
Nectarine 0.3 0.06 14.23 + 
0.109 
 
0.2214 1.4 21.9 
* Calculated based on methanol extract phenolic concentration and loaded 
volume of 180 ml 
 
 
From table 1 we can see the recovery of phenolics in the powder. From the original 
extracts, around 20% of phenolics were recovered after extraction and purification. This 
shows that in our methodology there are losses occurring. Chapter III will address these 
yield recovery losses for their test procedures.  
2.4.2 Thin Layer Chromatography 
 The detection of sugars, sterols, coumarins, terpenes, and arbutins was not found 
in the peach, plum, and nectarine powders. The main compounds detected in the stone 
fruit powders were polyphenolics. All three powders when tested for flavonoids showed 
orange fluorescence under UV light. With fluorescence behavior being structure 
dependent, orange TLC results suggests glycosides of quercetin, myricetin or luteolin.89 




characteristic of chlorogenic acid derivatives. The TLC plates for saponins showed some 
spotting for the three powders with the similar TLC behavior but different Rf values 
from the saponin standard. As the vanillin-sulfuric acid spray reagent is not specific for 
saponin compounds, some phenolics could also have similar colors. It has been reported 
that quercetin and rutin derivatives, hyperoside and myricetin have been reported with 
this assay previously when looking for saponins, especially from plant extracts.89This 
information as well as the negative terpene TLC tests tells us that most likely the 
spotting on the saponin TLC is from the phenolic flavonoids. Peach and nectarine 
powders were negative for phenolic anthocyanin compounds; the purified plum powder 
has anthocyanins, compositely, cyanidin 3-glucoside. Also the TLC results for 
flavonoids and anthocyanins comparing the original fruit extracts to the purified fruit 
powders confirmed that the detectable phenolics in the original fruit extracts were also 
present in the purified powders. 
2.4.3 Identification of Phenolics in Black Splendor Plum, Rich Lady Peach and 
Spring Bright Nectarine with High Performance Liquid Chromatography Diode Array 
Detection (HPLC-DAD) 
 HPLC analyses of samples were identified previously with UV spectra and ESI 
fragment patterns.   Results showed 13 compounds in Black Splendor plum (dark red 
skin, red flesh), including 2 chlorogenic acid derivatives, 2 anthocyanins, 6 flavonoids 
and 3 procyanidin derivatives (Table 2, Figures 4). In Rich Lady peach, 11 compounds 
were identified, including 2 chlorogenic acid derivatives, 4 flavonoids and 3 procyanidin 




types of anthocyanins, while many peach varieties only contain cyanidin 3-glucoside.7In 
black splendor, we found cyanidin 3-glucoside and cyanidin 3-rutinoside. 
 
Table 2. Phenolic profile in Black Splendor plum 
No. tR λmax Compound 
 1   2.869 232, 278 procyanidin  
 2 
 
  3.471 232, 280, 328 neo-chlorogenic acid 
 3   4.604 233, 278 catechin 
 4   5.260 233, 279, 330 chlorogenic acid 
 5   6.339 233, 279, 517 cyanidin 3-O-glucoside 
 6   7.138 233, 279, 519 cyanidin 3-O-rutinoside 
 7   7.756 233, 280 epi-catechin 
 8  14.458 237, 352 rutin 
 9  14.826 238, 352 quercetin 3-O-glucoside 
10  15.416 239, 347 quercetin 3-O-pentoside 
11  15.789 239, 347 quercetin 3-O-pentosylepentoside 
12  16.077 239, 351 quercetin 3-O-pentoside 
13  16.548 240, 353 quercetin 3-O-rhamaose 






Table 3. Phenolic profile in Rich Lady Peach 
No. tR λmax Compound 
 1   2.944 232, 278 procyanidin  
 2 
 
  3.468 232, 280, 328 neo-chlorogenic acid 
 3   4.105 233, 278 catechin 
 4   4.111 232, 278 procyanidin 
 5   5.068 233, 279, 330 chlorogenic acid 
 6   5.830 232, 278 procyanidin 
 7  14.635 237, 352 rutin 
 8  14.907 238, 532 quercetin 3-O-glucoside 
 9  16.195 239, 351 flavonoid 
10  16.582 240, 353 flavonoid 
11  17.480 240, 353 flavonoid 







 In peach, we found neo-chlorogenic and chlorogenic acids, rutin, quercetin 3-o-
glucoside, three procyanidin polymers, and three flavonoid polymers. For Spring Bright 
nectarine, we found 5 compounds, including 2 chlorogenic acid derivatives and 2 
procyanidin derivatives (Table 4, Figures 6). All stone fruits seem to have similar 
phenolic classes of compounds present, but in different proportions. Plum has the most 
anthocyanin content, while peach and nectarine are high in phenolic acids and flavonoid 






Table 4. Phenolic profile in Spring Bright nectarine 
No. tR λmax Compound 
 1   2.450 232, 278 procyanidin 
 2   3.474 232, 280, 328 neo-chlorogenic acid 
 3   4.475 233, 278 Catechin 
 4   4.673 232, 278 Procyanidin 
 5   5.066 233, 279, 330 chlorogenic acid 





 The data is comparative to other researcher’s identifications of stone fruit 





previous trials of SPE cleanup, where the majority of phenolics were lost in the process 
to remove sugars by the elution solvent of methanol alone (data not shown). Thus the 
method of using different solvent systems to play with the polarity and pH of the nature 
of the phenolic compounds was used. This method was previously proved to be also 
effective for stone fruit phenolics.87 Because the aim was to see the holistic effect of the 
fruit phenolics on cellular glucose 6-phosphate production, the SPE treated phenolic 
compounds were combined together as one extract (freeze dried to powder) for cell 
study use.  This is acceptable as our TLC work showed us that only phenolic compounds 
were present in the final extract powders. 
2.4.4 Effect of Stone Fruit Extracts on Cell Viability 
 Before determining the effect of the stone fruit extracts on the accumulation of 
intracellular G-6-P, it was necessary to evaluate if the extracts could elicit a cytotoxic 
effect in muscle cells. After 24 h of exposure to stone fruits extracts, the cell viability 
was determined using the MTS assay. Results showed that peach extract at 
concentrations > 100 μg/mL induced cell cytotoxicity (Figure 7 A).  For nectarine 
extracts, concentrations > 100 μg/mL showed a cytotoxic effect, reducing cell viability 
by about 40% (Figure 7 B). On the other hand, plum extract did not exhibit a cytotoxic 
effect until a concentration of 300 μg/mL (Figure 7 C). Based on the data obtained, the 
extract concentration range determined to use in this cell line, without altering cell 
viability was from 0-100 μg/mL for the peach, plum, and nectarine samples. The true 
total soluble phenolic content range of 0-100 µg dry powder/ml is 0-6.3 µg CAE/ml for 





Figure 7. Evaluation of cytotoxic effects of stone fruit extracts on muscle cells. Cells 
were exposed during 24 h to extracts from peach (A), nectarine (B) and plum (C) and the 
cytotoxic effect of phenolics from 0-300 µg dry powder/ml was measured using the 
MTS assay. Data are means ± S.D. (n= 8). Different letters denotes significant 




2.4.5 Differentiation of C2C12 Cells into Myoblasts and Development of a Model of 
Insulin Resistant Muscle Cells 
 The first step in the experiments with muscle cells is to induce the differentiation 
of the cells into myotubes, trying to emulate the behavior of a real skeletal muscle. In the 
process of myogenesis, satellite cells will proliferate into myoblasts which will then 
differentiate to multi-nucleated myotubes fibers; with maturation, these myotubes 
become the well-recognized myofibers that make up striated skeletal muscle. After four 
days of treatment with horse serum, the formation of myotubes is complete (Figure 8), 
and the cells are ready to be used in further experiments. 
 
 
Figure 8. Differentiation of C2C12 cells into myotubes. C2C12 cells were cultured in 
medium supplemented with FBS until 70% confluent (A), then the cells were cultured 
during 4 days in medium supplemented with horse-serum to induce the fusion of the 




 Once C2C12 cells complete their differentiation into myotubes, the induction of 
an insulin-resistance state was done by using palmitic acid. Previous studies have shown 
that palmitic acid is able to induce insulin resistance in muscle cells, reducing its ability 
to perform glucose uptake.91-95 Metformin, is a well-studied compound, used as a 
treatment for type 2 diabetes, because is able to induce the glucose uptake in skeletal 
muscle cells via AMPK pathway.96-98 The idea to incorporate the use of metformin in the 
experiments of quantification of intracellular concentration of glucose 6-phosphate, was 
to test if the insulin-resistant model generated in the myotubes was working properly, in 
addition to obtaining a reference value for the stone fruits extracts. Our data obtained in 
relation to the development of an insulin-resistant condition in the myotubes, showed 
that there is an increase in the basal intracellular concentration of glucose 6-phosphate in 
myotubes treated with palmitic acid, at levels comparable to control cells after 30 min of 
exposure to insulin. Despite this result was unexpected, there are previous reports 
indicating that palmitic acid acutely induce the activation of AKT, and consequently an 
increase in the glucose uptake.99 This extra-glucose present on the cells could be rapidly 
transformed into glucose 6-phosphate, by activation of the glucokinase, increasing its 
intracellular concentration. Nevertheless, palmitic acid treated cells (insulin-resistant 
cells) exposed to insulin are not able to increase the glucose uptake and therefore the 
intracellular concentration of glucose 6-phosphate remains unchanged compared to 





On the other hand, metformin is able to partially reverse the inhibitory effect of palmitic 
acid in the myotubes, increasing by 22.3% the intracellular concentration of G-6-P as 
compared to the insulin resistant cells. As expected, control cells exposed to insulin 
showed an increase (44.69%) of the intracellular concentration of glucose 6-phosphate 
compared to control cells non-exposed to insulin. Figure 9 is represented in two parts, 
the first being the intracellular glucose 6-phosphate accumulation in the cells as 
described earlier. The second part of the figure is the data transformed to show the net 
insulin stimulated values of intracellular glucose 6-phosphate, as insulin is the trigger 
hormone that activates glucose transporters to the cell membrane for glucose uptake into 
the cell, which is a crucial step in converting plasma glucose into glycogen, with the first 
process of this being the enzyme hexokinase converting newly taken glucose into the 
cell into the intermediate, glucose 6-phosphate.  Based in all this data, the possible 








Figure 9. Effect of Palmitic acid and insulin on glucose-6-phosphate accumulation in 
muscle cells. G6P accumulation (A) and net insulin stimulated G6P accumulation in 
muscle cells (B). Cells were cultured in absence or presence of 0.5 mM of palmitic acid 
during 48 h and exposed to 100 nM of insulin for 30 min to determine the intracellular 
concentration of G-6-P. Bars represent means ± S.D. (n = 3). Different letters denotes 






2.4.6 Effect of Stone Fruit Extracts on Muscle Cells 
 The stone fruits extracts were tested in the insulin-resistant myotubes described 
above. Results showed that plum extract had no effect on insulin-resistant myotubes, 
maintaining the concentration of glucose 6-phosphate similar to the control cells. On the 
other hand, nectarine extract showed a similar effect to metformin at 10 μg/ml, 
increasing the intracellular concentration of glucose 6-phosphate. Similarly, the peach 
extract at 1 μg/mL also showed an insulin-sensitizing effect (Figure 10). The fact that 
nectarine extract at 10 μg/mL and peach extract at 1 μg/mL are able to increase the 
intracellular concentration of G-6-P at levels comparable with metformin, a known anti-
diabetes compound, suggest that these extracts have the potential to be used as the basis 
for developing anti-diabetes drugs in the future. However, the mechanism of action for 
these extracts is not well elucidated and should be studied in more detail. The observed 
results for both extracts could be consequences of an increase of the glucose uptake or an 
increase in the activity or amount of the enzyme glucokinase, which is responsible of the 
transformation of glucose into glucose-6-phosphate. In figure 11, the data is transformed 
to show the net insulin stimulated glucose 6-phosphate, showing the visual differences in 





Figure 10. Effect of stone fruits extracts on intracellular glucose-6-phosphate 
accumulation in muscle cells. Cells were treated with 0.5 mM of palmitic acid during 48 
h to induce insulin resistance and treated with extracts from peach, plum and nectarine 
co-incubated with palmitic acid for an additional 16 h, before exposure to 100 nM of 
insulin for 30 min. Samples were collected immediately after exposure to insulin. 
Intracellular Glucose-6-phosphate was determined using a commercial kit. Bars are 
means ± S.D. (n= 3). Different letters denotes significant differences by ANOVA 











Figure 11. Effect of stone fruits extracts on net insulin stimulated intracellular glucose -
6-phosphate accumulation in muscle cells. Depicts the net insulin stimulated values of 
figure 10, taken by the difference in the insulin stimulated and control cells were treated 
with 0.5 mM of palmitic acid during 48 h to induce insulin resistance and treated with 
extracts from peach, plum and nectarine co-incubated with palmitic acid for 16 h, before 
exposure to 100 nM of insulin for 30 min. Samples were collected immediately after 
exposure to insulin. Glucose-6-phosphate was determined using a commercial kit. Bars 
are means ± S.D. (n= 3). Different letters denotes significant differences by ANOVA 







 Plum extract treated samples did not have a significant increase G6P 
concentration in respect to the control cells, however the peach and nectarine treated 
samples did show an increase. This is interesting as all the stone fruits contain similar 
phenolic profiles, but their composition varies, with the peach and nectarine phenolic 
compositions being similar. It is likely that it is either the phenolic acids, flavonoids, or 
catechin derivatives working in the cells to increase the G6P production, as these are 
abundant in the peach and nectarine samples. The peach and nectarine extracts could be 
working through many different ways to increase the G6P concentration including the 
insulin signaling pathway or the glucose metabolism steps in converting glucose to 
glycogen (figure 12). From these results we see a quick result of the fruit phenolic 
compounds on a marker of insulin resistance in muscle, with the next steps to research 







Figure 12. Diagram of possible mechanisms of action of peach and nectarine extracts in 
insulin-resistant myotubes. The phenolic extracts can be working to increase intracellular 
G6P through working on GLUT4 translocation, AKT increased phosphorylation, 
inhibiting ROS accumulation or inhibiting JNK and IRS1 serine phosphorylation. 





 In figure 12, we show a possible mechanism that the fruit phenolics might be 
targeting. Palmitic acid causes insulin resistance in muscle tissue by decreasing insulin 
receptor expression and activity as well as reducing downstream insulin signaling 
pathway activators such as IRS1 and AKT, key regulators in GLUT4 translocation and 
glucose uptake. Cellular factors to consider include palmitic acid’s effect on ROS 
accumulation and ER stress, affecting JNK and IRS1 receptor signaling as well as the 




exposure to palmitic acid is inhibiting the proper glucose uptake into the cells as seen on 
the control cells and cells treated with palmitic acid in their reduction in the 
concentration of intracellular glucose-6-phosphate (G6P). peach and nectarine extracts 
could be acting at two different levels, by increasing the glucose uptake as a 
consequence of an increase in the translocation of GLUT-4 transporters to the surface of 
the cell; or through an increase in the amount or activity of the enzyme glucokinase 
(GK), in which both pathways are in part due to the activation of AKT, which is partly 
activated by the insulin receptor substrate activity in the insulin signaling pathway. Both 
possibilities may lead to an increased concentration of G6P, indicating a reversion of the 
insulin-resistance state. Another possible area that the stone fruits are working is 
decreasing the ROS and activated JNK. Intracellular ROS accumulation and JNK 
activation lead to an inhibition in the insulin signaling pathway, and therefore inhibit 
G6P intracellular accumulation. Further research will be investigated later in this thesis 
to determine which phenolic compounds found in the extract are exerting this effect on 
the insulin resistant C2C12 myotubes. 
 Since peach and nectarine fruit phenolics are the same compound categories and 
since peach HPLC chromatograms had identified more individual phenolic compounds 
present in the samples peach will be studied further into this mechanism to view the 
specific effects of each category of phenolic compounds (phenolic acids, anthocyanins, 
flavonoids, and catechin derivatives) on specific sites of the insulin signaling pathway as 








Insulin resistance is a common precursor to T2DM and occurs when there is an 
inability of insulin sensitive tissues to transport glucose into the cell. In this study, 
peaches (Prunus persica var. Rich Lady) were extracted, purified, and separated into 
four fractions of polyphenolic compounds (phenolic acids (F1) anthocyanins (F2) 
catechins (F3) and flavonoids (F4) based on known chemistry reactions of the nature of 
the compounds with silica gel, pH, and solvent polarities using C18 SPE silica gel 
cartridges. Studies on the efficacy of the phenolic SPE separation method were done in a 
small scale trial (85% phenolic yield recovery after purification from extracts) and a 
scale-up production (48% yield recovery) for use in C2C12 myotube model. It was 
determined that with the correct solvent and pH system, phenolic acids and anthocyanins 
can be easily and distinguishably separated using this method; flavonol derivatives and 
catechins may also be separated, but as their polarity is so similar, complete isolation is 
difficult. From methods and recovery analysis it was determined that large scale 
production of clean phenolic extracts incur more losses due to stages involving solvent 
evaporation equipment, extraction ratio, and separation washing steps. The phenolic 
fractions were quantified for phenolic content with wet-based chemistry (Folin), 
compound identified with chromatography (HPLC-DAD), and used in an insulin 




glucose 6-phosphate, intracellular ROS, and immunochemistry. Muscle cells were 
induced to insulin resistance with 0.5mM palmitic acid and treated with fractions at 
ranges of 0-10 µg CAE/ml showed increased glucose uptake in cells (F1: 1.0 µg 
CAE/ml, F2: 0.1 µg CAE/ml, F3: 0.1 µg CAE/ml, F4: 0.5 µg CAE/ml). At these 
concentrations all fractions were able to increase glucose 6-phosphate intracellular 
accumulation similarly to control cells, with F3 showing no significant difference from 
palmitic acid induced cells. All fractions showed no significant effect on intracellular 
ROS, but were able to increase AKT phosphorylation similarly to control cells, and 
decrease JNK and IRS1 ser307 phosphorylation to levels of the controls. The fraction 
phenolics could be working through AMPK to regulate ROS and JNK production as it 
affects to IRS1 activation as well as through the transport of GLUT4 to the membrane 
for glucose uptake.  
3.2 Introduction 
Skeletal myotubes and adipocytes have been previously used as models for 
insulin resistance in vitro as they are the major sites of insulin stimulated glucose uptake 
in the body. Skeletal muscle accounts for over 80% of this uptake and therefore is a 
suitable cell culture model for studying the effects and potential reversals of insulin 
resistance symptoms. 4 ,12  Insulin stimulated glucose uptake is regulated primarily by the 
PI3K/insulin signaling pathway which begins with the insulin binding to its receptor 
ultimately leading to glucose transport vesicles to move to cell membranes to uptake 
glucose into the cell for transformation into glycogen for storage. Major players in the 




PI3K and AKT activation, and the glucose transporter vesicles. In cellular insulin 
resistance the insulin hormone is able to bind to its receptor on cell surfaces, however, 
the PI3K signaling cascade initiated after insulin: insulin receptor binding is altered by 
excess amounts of free fatty acids in the body that lead to a decrease in the amount of 
glucose uptake into the cells, leading to a state of high plasma glucose levels that 
eventually, along with β-cell dysfunction, leads to type II diabetes mellitus (T2DM).1, 49 
Phytochemicals have shown to have some beneficial effects on glucose uptake 
and insulin sensitivity in myotubes, adipocytes, hepatocytes, and pancreatic β-cells. 
Specifically, flavonoids have been found to inhibit ROS producing enzymes as well as 
quercetin regulating inflammatory cytokines.73 Anthocyanins were found to decrease 
fasting glucose and triglyceride levels and increase muscle cell glucose uptake. 76 
Finally, chlorogenic acids were able to increase GLUT4 translocation and glucose 
uptake, as well as decrease hepatic glucose production more than the common standard 
diabetic drug metformin. 81, 83Chapter II in this thesis analyzed the effects of peach, 
plum, and nectarine phenolic extracts on C2C12 insulin resistant cells and found that 
peach extracts were able to increase intracellular glucose 6-phosphate concentration 
more so than nectarine. The peach extract contained a mixture of hydroxycinnamic 
acids, anthocyanins, flavonols, and procyanidins. 
While the acting compounds in the peach fraction are known, and the total peach 
extract was able to increase intracellular G6P of murine muscle cells after being treated 
with palmitic acid, more research is needed to investigate what class of phenolic 




compounds having an effect. It is also worthwhile to look into other mechanisms that the 
phenolics could be acting that affect the insulin signaling pathway, such as the effect on 
intracellular ROS, as it leads to activation of JNK which inhibits the insulin signaling 
pathway. Therefore the next objectives will be to separate the phenolic compound 
classes found in peach and test them on the cells. By previous results, the peach contains 
four main compound classes: phenolic acids, anthocyanins, flavonoid derivatives and 
procyanidin polymers. These compounds will be chemically separated using SPE 
methods to be tested. For insulin resistance markers affected, G6P will be measured 
again, as well as glucose uptake as it is directly related to G6P. More elaboration in the 
pathway involves protein expression, specifically, AKT, IRS1, and JNK, as well as a 
look into intracellular ROS production. AKT is the main signaling protein in the insulin 
stimulated pathway; its activation stimulates glucose transporters for glucose uptake into 
the cell. Palmitic acid exposure in cell culture causes an increase in intracellular ROS 
production which in turn increases phosphorylation if the inflammatory cytokine JNK 
and IRS1 serine phosphorylation, both negative regulators of insulin signaling cascade. 
The phenolic compounds in peach may be targeting ROS and thus inhibiting the 
signaling pathway through negative regulators of insulin signaling. All of these markers 








3.3 Materials and Methods 
3.3.1 Plant Material 
Commercial variety of peaches (Prunus persica var. Rich Lady) were grown in 
California and collected at a mature stage and stored at 2-4oC. Upon arrival at Texas 
A&M University the pits were removed and fruits frozen at -80oC until further use. 
3.3.2 Extraction and Purification  
3.3.2.1 Rich Lady Peach Recovery Yield Study  
  13g of fruit cut in slices to preserve proportion between skin and flesh were 
homogenized (ultra-turrax (IKA. Works, Inc., Wilmington, NC)) with 40ml of methanol 
and left at 4oC overnight. Extracts were centrifuged at 15000 rpms for 15 minutes at 4oC 
and supernatants collected. Small aliquots were taken from the extracts for further 
analysis of methanol extract phenolics. The remaining methanol was evaporated at 45oC 
using a rotavapor (Buchi, Switzerland) until all solvent was removed and only the plant 
water content remained. The remaining aqueous extracts were re-diluted in distilled 
water until original extraction volume (40ml) purified of sugars and organic acids 
through a solid phase extraction (SPE) C18 cartridge system. Extracts were adjusted to 
pH 7 with 1N NaOH.  A repeated batch system  of 20ml extract per cartridge (2 
cartridge) was loaded into a C18 (55-105 µm, Waters Corp, Milford, MA) previously 
conditioned with 100ml methanol (pH 7) and 100ml distilled water (pH 7). The cartridge 
was washed with 200ml distilled water (pH 7) per batch.  The sugars, organic acids, and 
some phenolics acids were not retained on the cartridge (A). The water from the wash 




rotavapor (Buchii, Switzerland) and adjusted to pH 2 with 0.01% tri-flouroacetic acid 
(TFA). This water 20ml sample  was loaded onto a new C18 cartridge previously 
conditioned with 100ml methanol (pH 2) and 100ml distilled water (pH 2). The cartridge 
was rinsed with 200ml distilled water (pH 7), removing unwanted organic materials.  
The remaining phenolic compounds were eluted with 200ml 100% methanol (pH 7) 
(Fraction 1). The remaining compounds attached to the silica on the previous C18 
cartridge were collected with 200ml of the following solvents: 16% acetonitrile (pH 2) 
(Fraction 2); ethyl acetate (Fraction 3); and 100% methanol (Fraction 4). All four 
fraction solvents (400 ml each) were evaporated in a rotavapor until 50 ml. The 
recovered 50 ml was transferred and concentrated in the a centrivap concentrator 
(Labconco, Kansas City, MO) to minimize the losses due to loss of concentrated liquid 
during transfer from a large evaporating flask with small concentrated volumes. The 
concentrator tubes contain a maximum of 10ml, so 5 tubes of 10 ml for each fraction 
were evaporated until ½ their volume (5 ml per tube) and collected into 3 tubes of 10ml 
and the process was repeated until only one tube was needed per fraction. Each 10ml 










 There is few literature publications of product recovery after purification procedures 
and those that are reported vary greatly in recoveries from anywhere to less that 10% to 
upwards of 80% This step in the methodology was to reduce any losses that may occur 
to provide a most accurate yield recovery from our chemical separation. 
3.3.2.2 Rich Lady Peach Scale-up for Biological Study 
 100g of fruit cut in slices to preserve proportion between skin and flesh were 
homogenized (ultra-turrax (IKA Works Inc., Wilmington, NC)) with 400ml of methanol 
and left at 4oC overnight. Extracts were centrifuged at 15000 rpms for 15 minutes at 4oC 
and supernatants collected. Small aliquots were taken from the extracts for further 
analysis of methanol extract phenolics. The remaining methanol was evaporated at 45oC 
using a rotavapor (Buchi, Switzerland) until all solvent was removed and only the plants 
water content remained. The remaining aqueous extracts were reconstituted in distilled 
water to original volume (400ml) and purified of sugars and organic acids through a 
solid phase extraction (SPE) C18 cartridge system, as described in figure 13. Extracts 
were adjusted to pH 7 with 1N NaOH.  A repeated batch system  of 20ml extract per 
cartridge (20 cartridges) was loaded into a C18 (55-105 µm, Waters Corp, Milford, MA) 
previously conditioned with 100ml methanol (pH 7) and 100ml distilled water (pH 7). 
The cartridge was washed with 200ml distilled water (pH 7) per batch.  The sugars, 
organic acids, and some phenolics acids were not retained on the cartridge (A). The 
water from the wash containing the non-absorbed compounds from the fruit (2L) was 
concentrated to 20ml using a rotavapor (Buchii, Switzerland) and adjusted to pH 2 with 




cartridge previously conditioned with 100ml methanol (pH 2) and 100ml distilled water 
(pH 2). The cartridge was rinsed with 200ml distilled water (pH 7), removing unwanted 
organic materials.  The remaining phenolic compounds were eluted with 200ml 100% 
methanol (pH 7) (Fraction 1). The remaining compounds attached to the silica on the 
previous C18 cartridge were collected with 200ml per batch of the following solvents: 
16% acetonitrile (pH 2) (Fraction 2); ethyl acetate (Fraction 3); and 100% methanol 
(Fraction 4). All four fraction solvents were evaporated (4L each) in a rotavapor flasks 
for large volumes (400ml capacity) until 10ml which was then placed in a smaller 
volume evaporation flask (200ml capacity). The process was repeated until all volume 
was reduced into the smaller evaporation flask (100ml total) which was then evaporated 
completely until only phenolics remained, which was re-diluted to 1ml in 100% 
dimethyl sulfoxide (DMSO) and stored at 4oC until further use. Figure 13 describes this 










Figure 13. Solid phase C18 silica phenolic separation method.  Aqueous pH 7 
adjusted extracts (20ml extract to 10g sorbent) to a SEP PAK C18 cartridge previously 
conditioned with 100ml methanol (pH 7) and water (pH 7) using NaOH. The C18 
sorbent  is washed with water (pH 7, NaOH) and the wash is collected and concentrated 
back to original extract volume using a Rotovap (Buchi, Switzerland), adjusted to pH 2, 
TFA and added to a second C18 cartridge, preconditioned with 100ml methanol (pH 2, 
TFA) and water (pH 2, TFA). The C18 sorbent is washed with water (pH 2, TFA) and 
phenolic fraction collected with methanol (pH 7, NaOH) (Fraction 1). The original C18 
cartridge is fraction collected with 16% acetonitrile (pH 2) (Fraction 2), ethyl acetate 




3.3.4 Total Soluble Phenolics 
 Peach extracts and 4 fractions were tested for their amount of total soluble 




sample along with chlorogenic acid standard curve were diluted in 240 µl nanopure 
water in a 96 well microplate and reacted with 0.25N Folin-Ciocalteau reagent (15µl) for 
3 minutes and then 1N Na2CO3 (30µl) for two hours before reading the 
spectrophotometric value at 725nm. Sample amount of total phenolics were determined 
from the standard curve developed. Total soluble phenolics were expressed as mg 
chlorogenic acid equivalents (CAE)/ml sample. 
3.3.5 HPLC Analysis of Peach Extract and Fraction Phenolic Profiles 
  Peach extract and 4 fractions were tested for their phenolic compounds. Briefly, 
20 µL of filtered sample solution from peach extracted in methanol (1:4 (w/w)) and SPE 
separated fractions were injected after passing through a 0.22 µm nylon membrane. 
Individual compounds were identified based on retention time, UV spectra, and previous 
ESI fragmentation. Chromatographic separation was performed on a High-Performance 
Liquid Chromatography-Diode Array Detection (HPLC-DAD).  The HPLC system was 
composed of two 515 binary pumps, a 717-plus auto-sampler, and a 996-photodiode 
array detector (Waters Corp., Mildford, MA). Phenolic compounds were separated on a 
4.6mm×150 mm, 5 µm, C18 reverse-phase Atlantis column (Waters Corp.) that was 
maintained at 25 ℃ by a Spectra_Physics SP8792 column heater. The mobile phases 
consisted of 1% formic acid water (phase A) and acetonitrile (phase B) at a flow rate of 
1 mL/min. Separations were achieved by a linear gradient with A and B: 0 min 85% A, 5 
min 85% A, 30 min 0% A, 35 min 0% A. The injection volume was 20 µl. Data was 




was based on their UV spectra as compared with authentic standards and former samples 
identified before with UV spectra and ESI fragment patterns.   
3.3.6 Biological Material 
  The following chemicals were used in the experiments: palmitic acid, 
insulin,1,1-Dimethylbiguanide hydrochloride (metformin), Low Sugar-Dulbecco’s 
Modified Eagle’s Medium (DMEM), trypsin ethylene-diamine-tetra-acetic acid (EDTA), 
Dimethyl sulfoxide (DMSO), Bovine serum albumin (BSA), Fetal Bovine Serum (FBS), 
Horse Bovine Serum (HBS) and penicillin streptomycin mixture were purchased from 
Sigma (St. Louis, MO), glucose from Acros Organics (Fair Lawn, NJ) and sodium 
bicarbonate from Mallinckrodt Chemicals (Phillipsburg, NJ). Murine C2C12 cells were 
acquired from the American Type Culture Collection (ATCC) (Manassas, VA). Cell 
lysis buffer and antibodies for AKT (pan), IRS-1, p-AKT (thr308), p-AKT (ser473), p-
IRS-1 (ser307), p-IRS-1 (ser318), JNK, and p-JNK were obtained from Cell Signaling 
Technologies (Danvers, MA). 10% sodium dodecyl sulfate (SDS) solution, 30% 
acrylamide/bisacrylamide solution, N,N,N’,N’-tetramethylethylenediamine (TEMED), 
ammonium persulfate (APS), Tween 20, and Precision Plus Protein marker were from 
Bio-Rad Laboratories (Hercules, CA). Laemmli’s loading buffer was acquired from 
Fermentas Inc. (Glen Burnie, MD). Polyvinylidene fluoride (PVDF) membranes were 
from Millipore Corp. (Billerica, MA). Goat anti-rabbit-HRP polyclonal secondary 
antibody (A120-101P) was from Bethyl Laboratories (Montgomery, TX). Water used 
was nanopure grade. 




3.3.7 Cell Viability Assay 
 Cytotoxicity effects of peach fractions were evaluated in C2C12 myotubes using 
the MTS assay (Promega Corp., Madison, WI) according to the manufacturer’s 
instructions. The quantity of formazan product was measured at 490 nm and is directly 
proportional to the number of living cells in culture. The assay was performed in a 96-
well plate with a density of 1,500 cells/well. C2C12 cells were left with Low sugar 
DMEM/10% FBS medium until they reached around 70% confluent. Medium was 
replaced every 2-3 days. Once the cells were confluent, they were cultured with low 
sugar DMEM/10% Horse serum medium during four days, to induce myoblast 
formation. When the cell culture was induced to myoblast peach phenolic fractions were 
added for 24 h.  Previous to use, the peach phenolic fractions were diluted in 100% 
DMSO. The peach concentrations used were based on the folin results and were in the 
range from 0 to 80 µg CAE/mL, and the cell viability was measured after 24 hours of 
exposition to the fractions. The final percentage of DMSO per well was 0.5%. 
3.3.8 Measurement of Reactive Oxygen Species Production 
 1,000 C2C12 cells were placed in 96-well black and clear bottom plates (Costar) 
with growing medium (DMEM, 1mM glucose and 10% FBS) until they reached around 
70% confluent. Medium was replaced every 2-3 days. Once the cells were confluent, 
they were cultured with low sugar DMEM/10% Horse serum medium during four days, 
to induce myoblast formation. For ROS assay, the low sugar DMEM/10% HS medium 
was replaced with low glucose DMEM with serum free 2% BSA and 0.5 mM palmitic 




added during 16 additional hours co-incubated with palmitic acid in fresh serum free 2% 
BSA-low glucose-DMEM medium. In all cases, the serum free 2% BSA-low glucose-
DMEM medium was removed on the day of the experiment, and the cells washed two 
times with warm PBS and then incubated with 5µL M DCFA in DMEM 1mM glucose 
phenol red-free medium at 37oC for 30 minutes and the fluorescence was measured 
Ex/Em 485/535in a Microplate reader (Biotek, Vinooski, VT) . 
3.3.9 Generation of an Insulin Resistant Model and Treatment with Peach Fractions 
 C2C12 myoblasts were seeded at a density of 1,000 cells/ well in 24-well plates 
and cultured with low glucose DMEM with 10% FBS medium until they reached around 
70% confluence. Medium was replaced every 2-3 days. Once the cells were confluent, 
they were cultured with low sugar DMEM with 10% horse serum medium for 4 days, to 
induce myotubes formation. To the myotubes, 0.5 mM palmitic acid was added for 48 h 
to induce insulin-resistance. After exposure to palmitic acid the culture medium was 
replaced with fresh serum free 2% BSA-low glucose-DMEM medium, and the fraction 
treatments were added and co-incubated in presence of 0.5 mM palmitic acid for 16 h 
(2.0 mM of 1,1-dimethylbiguanide hydrochloride (metformin) was used as a positive 
control). After the treatments with the fractions, metformin and palmitic acid the cells 
were exposed to 100 nM of insulin for 30 minutes, and cells treated for experiments 
below 
3.3.10 Glucose Uptake in C2C12 Cells 
 Cells were cultured and treated with palmitic acid and peach isolate fractions 




glucose assay kit (Abcam. Cambridge, MA Catalog #ab65333) was used, per 
manufacturer’s instructions. Briefly, media was collected from the cultured cells and 
diluted with glucose assay buffer into a 96 well plate and mixed with a glucose reaction 
mix and incubated for 30 minutes at 37oC. A glucose standard curve was measured 
together with the samples, under the same conditions. The glucose present in the cell 
samples reacts with the glucose enzyme reaction mix to create a color compound visible 
at 570nm. The color produced is proportional to the glucose amount. Once incubation 
time was over, the amount of glucose in the media was measured in a microplate reader 
at 570nm for a colorimetric reading. Data was transformed to express the amount of 
mmole glucose uptake per well in the cells. 
3.3.11 Intracellular Glucose-6-phosphate Quantification in C2C12 Cells  
 Cells were cultured and treated with palmitic acid and peach phenolic fractions 
under the conditions described above. To measure the intracellular amount of Glucose-6-
phosphate, the PicoProbe™ Glucose-6-phosphate assay kit (BioVision. Milpitas, CA, 
Catalog #K687100) was used, following the manufacturer’s instructions. Briefly, 
cultured cells were lysed and centrifuged to remove insoluble cellular material. The 
neutral pH samples were placed in duplicated in a 96-well plate (black body, clear 
bottom, COSTAR) and incubated at 37°C, protected from light, with the reaction mix for 
30 minutes. A glucose-6-phosphate standard curve was measured together with the 
samples, under the same conditions. The glucose present in the samples and the known 
standard curve reacted with the G6P reaction mix to create a fluorescence that is directly 




amount of glucose-6-phosphate was measured in a microplate reader at Ex/Em = 
485/560. Data was calculated according the manufacturer’s instructions and expressed as 
mmoles G6P/well. 
3.3.12 Immunoblotting 
 The muscle cells C2C12 were harvested with a cell lysis buffer (Cell signaling 
Beverly, MA) following the manufacturer’s instructions. Each 6 well plate was washed 
with ice cold PBS (Sigma), added 100 μL lysis buffer, and containing protease inhibitor 
cocktail (Abcam Cambridge, MA). Cells were then scraped, left incubated at -80 ºC 
overnight, centrifuged at 14,000 rpm at 4 ºC for 15 min and supernatant was aliquot and 
stored at -80 ºC. The total protein was quantified using the BCA Protein Assay Kit 
(Pierce, Thermo Fisher Scientific, Inc., Rockford, IL) and 50 µg of protein were loaded 
on a gel with a pre-stained, broad-range, molecular weight protein marker (Fermentas). 
Proteins were fractionated by electrophoresis using 10% polyacrylamide gels made by 
mixing 9 ml of 22.2% acrylamide/0.6% Bis., 7.5 ml of 1M Tris//HCl (pH=8.8), 3.2 ml of 
nanopure water, 200 µl of 10% SDS, 100 µl of 10% ammonium  persulfate, and 10 µl 
TEMED. The gels were transferred by wet blotting onto PVDF membranes (Millipore). 
The membranes were blocked with 5% BSA in Tris-buffered saline with 1% Tween-20 
(TBS-T) for 2 h with gentle shaking; five times of 5 min washes with TBST were 
performed consecutively. Membranes were then incubated with specific primary 
antibodies against phosphorylated-AKT, AKT, phosphorylated-IRS, IRS, 
phosphorylated-JNK, JNK and b-Actin following the manufacturer's recommendations 




incubated for 1 h with the secondary antibody conjugated with horseradish peroxidase 
(HRP) at 1:30000 dilutions. Specific bands were developed using a Super Signal West 
Femto enhanced chemiluminescence (ECL) Western blotting detection kit (Pierce, 
Thermo Fisher Scientific, Inc., Rockford, IL) after 60 seconds incubation the signal were 
captured by CCD Camera (Cascade II:512, Photometrics, Tucson, AZ) using the Win 
View/32 software (Version 2.5, Princeton Instruments, Trento, NJ). Bands were 
measured and quantified using densitometry with Image J software (NIH, Bethesda, 
MD). For JNK isomers, both bands densitometry quantifications were averaged. 
3.3.13 Statistical Analysis 
 The data were analyzed using one-way analysis of variance (ANOVA) followed 
by tukey-kramer HSD, using the software JMP v9.0. Results are expressed as means ± 
standard deviations (S.D) of at least 6 independent experiments. Different letters show 
significant differences (P < 0.05). 
3.4 Results and Discussion 
3.4.1 Quantitative Analysis of the Recovery Yield of Total Soluble Phenolics from 
Peach Extracts Purified through C18 Cartridge and Peach Fractions Used for Cell 
Culture Treatments 
3.4.1.1Analysis of Recovery Yield of Peach Fractions Total Soluble Phenolics 
 The total soluble phenolics of the trial peach extract and purified fractions are 
represented in below. Using the amount of soluble phenolics per gram of fruit, the 
amount of phenolics loaded onto the C18 cartridge may be predicted, and with the 




determined. With a net loss of 1.16 mg CAE, it can be calculated that the yield recovery 
of phenolic compounds from the sum of the four fractions as compared to the original 
extract is ~85%, based on the total soluble phenolics wet based chemistry assay. This 
number shows a relatively efficient process in purifying and separating phenolic 
compounds from plant materials. It is worth to mention here that there should always be 
yield losses in any extraction to purification or separation processes. Some ideas as to 
the loss in phenolics here can be placed to human error, the heating element brought on 
by concentration of samples, and the chemistry of the silica gel itself but the main reason 
for losses in this experiment come from samples losses in concentration and equipment 
used. When comparing results in Chapter II, the yield of recovery was an issue of 
phenolic solution recovery from the rotavapor sample flask. When drying large amounts 
of solvents to small volumes final concentrated samples are viscous and never 
completely recovered from the evaporating flask. After running this controlled yield 
study experiment with a smaller scale extraction the centrivap concentrator could be 
used, where the room for losses is much smaller due to fewer losses from transferring 
solutions and we had an acceptable yield recovery (84.6%). This hypothesis of losses 
occurring from the evaporating equipment was also confirmed from Chapter II results on 
obtaining freeze dried powders. The extracts in the Chapter II were left to evaporate until 
all organic solvent was rotavapor evaporated and all that remains aqueous solution. The 
aqueous solution was difficult to remove from its container for lyophilization without 
losses occurring due to the flask walls, and the final phenolics found in the powder 




CAE/ml for plums, 0-1.2 µg CAE/ml for peach, and 0-1.4 µg CAE/ml for nectarines) 
with a phenolic yield recovery around 20% for all fruits. These true levels of phenolic 
compound exposure to the cell were taken into consideration in this chapter’s phenolic 
dosage and treatments to the cell line. 
   Overall, SPE C18 methods can be a fast, easy and inexpensive way to separate 
and purify certain components of natural product matrices, as long as there is knowledge 
of polarity and acidity and the behavior of the silica and the compounds of interest. 
Because methanol has good extraction proficiency, a clean-up system is needed after 
extraction, as unwanted impurities from the fruit matrix are likely to be present also in 
the extract. Solid phase extraction (SPE) clean-up systems are useful for fairly clean end 
extracts. For SPE of phenolic compounds the solid phase is usually a C18 sorbent 
bounded to silica.100 SPE has 50 times more separation power than a typical liquid-liquid 
extraction.101  For C18 extractions, samples are pretreated for the column and eluted 
from the column with normally 6-10 volumes of solvent load. For reverse phase 
chromatography, elutions occur from weak to strong organic solvents as weak organic 
solvents elute slowly down the column and lead to a strong particle retention while 
stronger organic solvents pass quickly and allow analyte passage. Table 5 contains the 
fractioned samples are presented as concentrated phenolic solutions compared to the 
original extract containing phenolics as well as other unwanted materials. Fraction 2 
seems to have the highest phenolic amount compared to the other fractions; however 




biological studies will be standardized to the same concentration based on their 
chlorogenic acid equivalency for homogeneity and control in the experiments. 
 
Table 5. Yield recovery studies of Rich Lady peach through SPE C18 silica gel 
Sample Measured Total soluble Phenolics 
[mg CAE/ml] 
Final Totals 
Rich Lady Peach Extract 0.6* + 0.03 13 g fruit 
Peach Fraction 1 1.07  1 ml collection 
Peach Fraction 2 3.65  1 ml collection 
Peach Fraction 3 1.17  1 ml collection 
Peach Fraction 4 0.70  1ml collection 
mg phenolics loaded onto C18 cartridge:     7.80 mg CAE                             84.6% 
mg phenolics sum of fractions recovered:     6.60 mg CAE                           recovery 
*Expressed as [mg CAE/g fresh weight] 
 
 
 The yield study samples were evaporated in the rotavapor until 50 ml, an amount 
experimentally found to be easily transferrable out of the sample flask with minimal 
losses. The remaining solution was evaporated in a centrivap concentrator, capable of a 
10ml sample flask holding capacity. With a smaller sample flask container the final 
phenolic removal showed minimal losses, as there was less surface area to leave sample 
residue. Reasoning behind this is the pure size of the experiments. The rotavapor is 
meant for evaporating solvents at high volumes (up to 1000mL capacity) while the 
centrivap can hold test tube up to 10ml capacity. It was not plausible to recover any 




amount of sample; therefore, the centrivap was used. For the centrivap study, the 50ml 
rotavapor reduced solutions had to be placed in 5 10ml tests tubes per fraction into the 
centrivap. These 10ml were reduced to ½ of their volume and then reduced to three 10ml 
test tubes and repeated until each fraction was completely evaporated into just one 10ml 
test tube. Afterwards there is no transfer of small solutions that could lead to high losses, 
but just a re-dilution in 1ml 100% DMSO for phenolic analysis to confirm the yield. 
3.4.1.2 Analysis of Scale-up Peach Fractions Total Soluble Phenolics 
 From the extraction and purification through SPE from the fruit used for the 
bioassays presented in table 6, the final phenolic recovery was much lower than what 
was recovered in the yield study, as depicted in table 5. From the 100 g of fruit with 0.32 
mg CAE/g fruit, 32 mg CAE of phenolics were put through the C18 silica gel. From the 
folin quantification of the fractions 15.7 mg CAE phenolics were recovered. This gives a 
49% yield recovery of the phenolic compounds from the 100g of peach fruit  Total 
soluble phenolics for the biological assays were determined as mg CAE for each fraction 
and the original extract aliquot. The results are presented in table 6. The extract was 
taken from a mixture of peel and flesh. These values recorded higher phenolic values for 
the peel extracts than our extract, (0.32 mg CAE/g fruit), and lower values for the flesh 
extracts than our extract, showing that the concentration is higher in the skin of the fruit 
rather than the flesh and our extract shows the phenolic content of the peach as a 
whole.102 The experiment for the biological study experiments used the same separation 
procedure as the yield study, however this was done on a much larger scale, and the 




study in that the centrivap concentrator for small volumes was not used, and losses from 
removing solvent from a larger sample flask could account for the large yield losses 
from the original fruit. These yield losses are permissible as we verified though our yield 
study that the methodology works for obtaining high quality yields of phenolic 
compounds from non-pure extracts and as the phenolics are standardized before 
treatment of cell culture, the actual phenolic content added to the cells is known, as well 
as the HPLC chromatograms confirmation that the type and ratio of phenolic compounds 
remains the same for both experiments, indicating no alterations in the phenolic profiles. 
 
 
Table 6. Total soluble phenolics of Rich Lady peach extract and fractions 
Sample Measured Total soluble phenolics  
[mg CAE/ml] 
Final Totals 
Rich Lady Peach Extract 0.320* + 0.21 100 g fruit 
Rich Lady Peach Fraction 1 2.580 + 0.16 1 ml 
Rich Lady Peach Fraction 2 8.610 + 0.18 1 ml 
Rich Lady Peach Fraction 3 1.450 + 0.11 1 ml 
Rich Lady Peach Fraction 4 3.020 + 0.23 1 ml 
Phenolics loaded C18 32 mg CAE 48.9% 
Phenolics recovered C18 15.66 mg CAE Recovery 
*Expressed as [mg CAE/g fresh weight] 
 
 
 In the 100g scale up of the procedure more materials such as extraction and 




different concentration processes. For the 100g fruit processing for the bioassays, the 
large amount of solvent that was passed though the C18 cartridge for fractionation was 
evaporated with the rotavapor, as this evaporator can hold large volumes of solvent to 
evaporate. After evaporation of the solvent much sample residue remained coated the 
walls of the flask and was unable to be transferred out of the sample flask. There are 
many other opportunities for product loss when scaling up the phenolic concentration for 
cell use. From 85% from the 13 g fruit sample, two 10 g silica C18 sorbent phase is used 
for clean-up and purification. For 100g fruit extraction, batch systems of twenty 10g 
sorbent cartridges are needed to prevent the risk of overloading any one cartridge with 
compound. Even so, this is not as effective as large silica packed column with a sorbent 
weight heavy enough to pass the entire sample through one time. Losses can develop 
with batch separation of one sample for clean-up and purification, as well as during the 
transfer from the sample flask after solvent evaporation. This yield study shows that the 
methodology is efficient at separating phenolic compounds by their chemical structures 
with minimal losses but if larger phenolic concentrations are desired the technology 
should be adapted to correct processes and equipment that cause product loss that occurs 
when scaling up the procedure. 
3.4.2 Identification of Phenolics in Rich Lady Peach Extracts and Fractions with 
High Performance Liquid Chromatography Diode Array Detection (HPLC-DAD) 
 HPLC analysis showed 7 compounds in Rich Lady crude extract including 2 
chlorogenic acid derivatives, 1 anthocyanin, 3 flavonoids and 1 procyanidin derivatives 




Lady peach varieties. In an analysis by HPLC-DAD of a Rich Lady extract done 
previously by Noratto and others, three peaks were determined: neo-chlorogenic acid, 
cyanidin 3-O-glucoside, and quercetin 3-O-glucoside.87 Another HPLC-DAD analysis 
done by Tomas-Barberan and others found in the flesh and peel of Rich Lady: neo-
chlorogenic acid and chlorogenic acid (main), around equal levels of catechin and 
procyanidin B1 as well as slightly lower amounts of epicatechin, quercetin 3-O-
galactoside, glucoside, and rutinosides, as well as cyanidin 3-O-glucoside and trace 
amounts of cyanidin 3-O-rutinoside, found only in the peel extracts.7 Our extract showed 
the same compounds as listed above, with the exception of cyanidin 3-O-rutinoside, 
which could be due to the fact that we extracted a peel and flesh extract, whereas 
cyanidin 3-O-rutinoside was reported in trace amounts in a peel only extract. 
 
 
Table 7. Phenolic profile in Rich Lady peach crude extract 
No. tR λmax Compound 
 1   2.64 232, 278 procyanidin  
 2   3.03  232, 280, 328 Neo-chlorogenic acid 
 3   4.23 233, 279, 330 chlorogenic acid 
 4   5.16  233, 279, 517 cyanidin 3-O-glucoside 
 5 14.57 237, 352 Rutin 
 6 16.00  238, 352 quercetin 3-O-glucoside 


















Figure 15. HPLC Chromatogram of crude extract at 320 nm with phenolic compound 
identification as listed by table 6 
 
 
 In fraction 1, 4 compounds were identified, including 2 chlorogenic acid 
derivatives, 1 anthocyanin and 1 procyanidin derivatives (Table 8, Figure 16). 
Previously, the silica C18 separation method was used to isolate phenolic fractions from 
an original extract from plums and peaches. Previously, Noratto and others separated a 
phenolic acid fraction from rich lady peach and obtained a fraction containing neo-
chlorogenic acid and chlorogenic acid.87The same silica and solvent system was used 
here. The idea of the C18 clean up system for phenolics uses the basis that the organic 
compounds will stick to the silica sorbent while during washing with water, hydrophilic 
compounds such as organic acids and sugars will elute off the column, leaving the 
organic material to be eluted off with organic solvents with similar polarity to the 
compounds of interest. In the case of phenolic acids, their elution is dependent on pH, as 
their hydrophobic affinity changes due to association/dissociation. In cases of neutral pH 




method this water elution was added to a second cartridge but this time at a low pH 
environment. At a low pH, phenolic acids will absorb to the C18 phase due to its non-
polar behavior. Once absorbed the phenolic compounds will have more affinity for a 
slightly more organic phase over water, thus during washing, the remaining acids will 
remain on the column until eluted with the correct polarity solvent. By the HPLC 
chromatogram the methodology worked well, with mostly phenolic acids separated with 
lower amounts of epi-catechin and cyanidin 3-glucoside recovered as well, most likely 
due to overloading of the C18 cartridges, and thus these phenolic fell out of the silica 
with the water washing. 
 
 
Table 8. Phenolic profile in fraction 1 
No. tR λmax Compound 
 1   3.87  232, 280, 328 Neo-chlorogenic acid 
 2   4.03  233, 279, 330 chlorogenic acid 
 3   4.86 233, 279, 517 cyanidin 3-O-glucoside 
 4   5.76 233, 280 epi-catechin 









Figure 16. HPLC Chromatogram of fraction 1 at 320 nm 
 
 Fraction 2 (Table 9, Figure 17) only has 1 anthocyanin, cyanidin 3-O-glucoside. 
This shows an acceptable purification of anthocyanins from C18 with acidic 16% 
acetonitrile, as no other compounds were found in this fraction. In the water washing 
phase, the anthocyanins will remain on the solid phase, allowing interfering compounds 
to elute, however with an organic polar solvent, the anthocyanins may be eluted. Two 
methods may be used after this step: first, remove all other polyphenols from the 
cartridge with ethyl acetate or similar solvent, before eluting the anthocyanins with an 
acid, more polar solvent such as methanol, or first elute the anthocyanins from the 
cartridge as proceeded with in this experiment, by selecting a polarity solvent that will 
only elute anthocyanins (16% acetonitrile) at an acidic pH = 2, anthocyanins are most 
stable.100, 103 If methanol or another solvent system is used to separate the anthocyanins 
first without previously removing all other compounds, the isolation will not be so 




therefore with 16% acetonitrile at an acidic pH, elution of only anthocyanins from the 
cartridge is possible. 
 
 
Table 9. Phenolic profile in fraction 2 
No. tR λmax Compound 
 1   4.23 233, 279, 517 cyanidin 3-O-glucoside 
    
 
 
    
 
    
 
Figure 17.  HPLC Chromatogram of fraction 2 at 520 nm. First peak shown on graph is 
solvent peak of DMSO 
 
 
 In fraction 3 (table 10, figures 18, 19), 9 compounds were identified including 2 
procyanidin, 2 chlorogenic acid derivatives and 5 flavonoids. The polarity and structure 





similar and therefore it is difficult to obtain a pure fraction of only flavonols and one of 
only catechin derivatives. The same is seem with HPLC elutions of these compounds as 
they have very close peaks, and therefore some flavonoid derivatives that are hard to 
quantify to a specific structure. In the fractionation procedure it was thought that with 
ethyl acetate the flavonols would elute, and later with the methanol, the catechins would 
elute. From the chromatograms and phenolic identification it seems that the third 
fraction eluted most of the remaining phenolic compounds left on the silica cartridge 
after elution of phenolic acids and anthocyanins.  
 
 
Table 10. Phenolic profile in fraction 3 
No. tR λmax Compound 
 1   2.74 232, 278 procyanidin  
 2   3.46  232, 280, 328 Neo-chlorogenic acid 
 3   4.44  233, 279, 330 chlorogenic acid 
 4   5.94 232, 278 Procyanidin 
 5 15.08 237, 352 Rutin 
 6 16.10 238, 352 quercetin 3-O-glucoside 
 
7 17.10 239.351 Flavonoid* 
8 22.12 240.353 Flavonoid* 
9 23.81 240.353 Flavonoid* 







Figure 18. HPLC Chromatogram of fraction 3 at 280nm and 350nm 
 
 
Figure 19. HPLC Chromatogram of Fraction 3 at 280 nm with phenolic compound 







Table 11.  Phenolic profile in fraction 4  
No. tR λmax Compound 
 1   8.72 232, 278 procyanidin  






Figure 20. HPLC Chromatogram of fraction 4 at 350nm 
 
 
 For fraction 4, we found 1 procyanidin (Table 11, Figure 20). Fraction 4 did elute 
one procyanidin polymer, possibly complex in structure and slow to elute down the solid 
phase with ethyl acetate, and the extra wash with methanol finally released it from the 
column. Noratto et. al. were able to identify quercetin derivatives in their ethyl acetate 
fraction 3, but in their methanol fraction 4, only small amounts of cyanidin 3-glucoside 
could be determined.87 In that study it was most likely that the cartridge was overloaded, 
and after flavonol elutions with ethyl acetate, the methanol released any remaining 
compounds in the cartridge, in this case, cyanidins.87  In our case, in fraction 3, we do 




contains a procyanidin, this by name, is our procyanidin fraction. With the compounds 
present in rich lady, the C18 methodology of cleaning and isolating the phenolics based 
on their pH and polarity tendencies worked well, with phenolic profiles similar to that 
what was theorized in the isolation procedure method. Perhaps with a different column 
or solvent systems, the separation of flavonoid compounds, mainly flavonols from 
procyanidins may be achieved with more separation. The separation of anthocyanins is 
well reported and in this protocol, was achieved with excellent separation. The isolation 
oh phenolic acids was also achieved in this protocol, but a cleaner isolation would have 
been possible if there was less of an overload of the C18 cartridge. Overall, C18 
separation methods are useful in the separation of phenolic compounds in large volumes 
for use in biological assays. While there are other methods that are used for cleaner 
separations, their final yield is low in volume and may only be used for few chemical 
experiments, but cannot be produced in high enough quantities for further biological 
experiments like C18 solid phase extraction has shown. 
3.4.3 Effect of Peach Fractions on Cell Viability 
 Before proceeding with any experiment, it was necessary to determine the 
concentration levels that cause cytotoxicity in the cells. After incubation with the fruit 
fractions for 24 hours, the cytotoxicity was measured according to the MTS assay. 
Results showed that after a concentration of 10 µg CAE/ml there is an induction of 





 For fraction 1, there appears to be no drastic effect on cell death based on the results 
(figure 21A), however statistical differences do appear at higher concentrations. 
 In fraction 2 and fraction 4, there are similar cell death inductions after 10 µg CAE/ml 
(figure 21B, D). For fraction 3, there is a clear induction of cell death after 5 µg CAE/ml 
(figure 21C). The harsh effect of fraction 3 on the cells is based on the chemical 
composition of the compounds found in the fraction, with many flavonol and catechin 
derivatives. Based on the data obtained, the concentration range for the remaining 
experiments will range from 0 – 5 µg CAE/ml, with the exception of fraction 3 (0 – 1 µg 
CAE/ml) and fraction 4 (0 - 10 µg CAE/ml). In Chapter II, even though higher levels of 
extracted powder were used on the cell culture, the actual phenolic content of these stone 
fruits treated was much lower (0.014ug/ml-0.063ug/ml). Know the phenolic range to add 
to our cells as well as their results in Chapter II we tested our cytotoxicity within the 









Figure 21. Peach fractions cytotoxic effects on C2C12 differentiated cells. A: phenolic 
acid fraction (fraction 1), B: anthocyanin fraction (fraction 2), C: flavonoid fraction 
(fraction 3), D: procyanidin fraction (fraction 4). Differentiated cells treated with 
phenolic fractions for 24 hrs. Bars represent means ± S.D. (n = 3). Different letters 





3.4.4 Differentiation of C2C12 Myoblasts and Development of an Insulin Resistant 
Cell Model  
 In the process of myogenesis, satellite cells will proliferate into myoblasts which 




myotubes become the well-recognized myofibers that make up striated skeletal muscle. 
For the following assays, the differentiation of C2C12 myoblasts into myotubes must 
occur. After 4 days of exposure to horse serum, the myotubes are ready for insulin 
resistance. After differentiation, C2C12 cells were induced with palmitic acid to an 
insulin resistant state. There have been many references that state saturated fatty acids, 
namely palmitate, can induce an insulin resistant state in muscle cell culture, inhibiting 
cellular AKT activation, decreasing GLUT4 translocation, and preventing insulin 
stimulated glucose uptake and glycogen synthesis.92-95, 104-108 Metformin was used as a 
positive control to verify the insulin resistant model’s effectiveness as well as provide a 
reference value for the peach fractions for comparison.  With glucose uptake, we found 
that metformin was able to partially reverse the effects of palmitic acid on the myotubes 
(figure 22). Based on this data, the C2C12 insulin resistant model was used for the 







Figure 22. Effect of palmitic acid and metformin on glucose uptake and net insulin 
stimulated glucose uptake. Cells were cultured in absence or presence of 0.5 mM of 
palmitic acid during 48 h and exposed to 100 nM of insulin for 30 min to determine the 
glucose uptake. A._ Depicts glucose levels of insulin and non-insulin stimulated cells. 
B.) The increase in glucose uptake is depicted using reference control cells non-exposed 
to insulin. Bars represent means ± S.D. (n = 3). Different letters denotes significant  





3.4.5 Effect of Peach Phenolic Fractions on Glucose Uptake in Muscle  
 The objectives of this study were to evaluate a possible effect of peach phenolic 
fractions against type 2 diabetes.  The approach used to evaluate this effect, was the 
measurement of the glucose uptake and intracellular concentration of glucose-6-
phosphate (G6P), which is the direct product of the activity of glucokinase (GK), a key 
enzyme that functions to carry out the first reaction of glucose metabolism: the ATP-
dependent phosphorylation of glucose into glucose-6-phosphate.11 Our results might 
indicate that peach phenolic extracts increase the glucose uptake significantly on muscle 
cells exposed with palmitic acid an inductor of insulin resistance (Figure 23). These 
findings coincide with other in vitro reports studying the activity of chlorogenic acids 
and anthocyanins, with reports that chlorogenic acid stimulates basal and insulin 
mediated glucose transporters in muscle cell culture as well as activates AKT.109  The 
effect of caffeic acid on intramyocellular glucose uptake have also been studied with 
results noting that Caffeic acid enhances glucose uptake in muscle and adipose cells in a 
concentration dependent manner.110-111 Chlorogenic acid’s molecular structure is that of 
caffeic acid esterified to quinic acid, therefore, the caffeic acid molecular structure of 








 Anthocyanins have also been reported for their ability to enhance skeletal muscle 
insulin mediated glucose uptake. Anthocyanin reports include the ability to enhance 
glucose transporters in skeletal muscle of diabetic rats and increase total body insulin 
sensitivity in insulin resistant participants.112-114 Studies have shown that quercetin 
glycosides enhance glucose uptake, but do so independently of insulin stimulation, most 
likely by the AMPK pathway.115 Another study shows that flavonoids such as quercetin 
and catechin-gallate inhibit glucose uptake in adipocytes over the concentration range of 
10-100 uM.116 These may be possible reasons why fraction 3 does not show any glucose 
uptake enhancement higher than our positive control (Figure 23).  This glucose uptake 
assay will determine the single concentrations of each fraction for further studies on this 
cell line, with the highest effect in consideration. For fraction 1, the concentration used 
for further study is 1µg CAE/mL and for fractions 2 and 3 it is 0.1µg CAE/mL and for 















Figure 23. Effects of peach phenolic fractions on insulin stimulated glucose uptake in 
muscle cells (C2C12). Cells were treated with 0.5 mM of palmitic acid during 48 hours 
to induce insulin resistance and treated with peach phenolics fractions co-incubated with 
palmitic acid for additional 16 hours (A: Fraction 1, B: Fraction 2, C:Fraction 3, D: 
Fraction 4) previous to be exposed to 100 nM of insulin for 30 minutes. Palmitic acid 
(PAL) and metformin (MET) were also measured. Samples were collected immediately 
after exposure to insulin. Glucose was determined using a commercial kit as described in 
materials and methods. Bars are means ± S.D. (n= 5). Different letters denotes 
significant differences using one-way analysis of variance (ANOVA) followed by tukey-









 From figure 23 it shows that all four fractions are successful at increasing 
glucose uptake into the cell, even some more than the tested level of metformin used. 
However, it is important to note the fraction concentrations that stimulated glucose 
uptake above the level of metformin. Metformin is usually given at a dose effective at 
reverting insulin resistance but too high a concentration can cause excessive glucose 
uptake into the cells and thus develop cases of hypoglycemia in the blood. Cases of 
hypoglycemia have been reported even under normal dosing regimen.117 These results 
show that the different phenolic types present in Rich Lady peach are effective at 
reverting the process of insulin resistance like metformin but perhaps for further research 
purposes it would be better to look at these peach fraction levels at concentrations that 
do not exceed the tested level of the positive control as to not produce a state of 
hypoglycemia in the body. Also for future experiments, deoxyglucose could be used as 
an alternative method to measure glucose uptake as it is accurate and widely used in the 
literature. Also for future experiments, deoxyglucose could be used as an alternative 
method to measure glucose uptake as it is accurate and widely used in the literature. 
Flouro-deoxyglucose assays for studying glucose uptake in cell culture are the most 
common assays found in the literature.118 The basis for this assay is that glucose and 
deoxyglucose are transported in the same manner into the cells and phosphorylated by 
hexokinase, but unlike glucose it accumulates as it cannot be rapidly transformed into 
G6P like glucose is in the cell. It measures total glucose uptake, including those 




measure GLUT as well as glucose uptake.118 Another note to mention is that the number 
of cells needed for deoxy-glucose is less than our current glucose uptake assay.   
 The negative glucose uptake observed by some higher concentrations of peach 
fractions two and four could in fact be due to multiple causes. As the cytotoxicity results 
showed no visual changes at higher concentrations for some samples but a statistical 
significant difference it could be hypothesized that the negative glucose uptake at these 
high concentrations could be due to cytotoxicity occurring in the cells. Another 
explanation for the negative concentrations could be explained by the phenolic 
compounds at higher concentrations are actually eliciting glucose release from these 
cells through some mechanistic pathway. Because of this we cannot assume at high 
concentrations with these compounds that there will not be any detrimental effects. For 
further research purposes it would be worthwhile to look at these compounds at smaller 
concentrations to view their activity on glucose uptake and the insulin signaling 
pathway, as these smaller level seem to increase insulin sensitivity at levels that would 
mimic normal conditions of homeostasis in the entire system. 
3.4.6 Intracellular Glucose 6-Phosphate 
 After glucose is taken into muscle cells by transport vesicles, most of it is sent 
though pathways for glycogen synthesis. Intramyocellular glucose is first transformed 
into an intermediate G6P in the pathway. G6P intracellular concentration was measured 
as described above for C2C12 myotubes.  The results are shown in figure 24. The 
control cells with palmitic acid show a significant decrease from the control cells 




working to create an insulin resistant model. Fraction 2 at a concentration of 0.1 ug 
CAE/ml showed similar increases in G6P comparable to the positive control, metformin. 
Fraction 1 at 1 ug CAE/ml and fraction 4 at 0.5 ug CAE/ml also showed increases in 
G6P, however not as high as an increase as fraction 2. Fraction 3 at 0.1 ug CAE/ml 
showed the least amount of G6P concentration, showing no significant difference from 
palmitic acid treated cells. This could be due in part to the large sample variation for 
fraction 3. When measured with only a standard t-test against palmitic acid control cells, 
F3 was able to show statistical difference (p<0.05). All fractions did increase the amount 
of intracellular G6P relative to the control. These results shown agree with the results 
obtained from the glucose uptake assay, in which the highest amount of glucose uptake 
was found in fraction 2 at 0.1 ug CAE/ml, followed by fractions 1 and 4, and with 
fraction 3 having the least amount of glucose uptake. As the amount of glucose taken 
into the myotubes is related to the amount of G6P produced in the cells, these results 
show a strong correlation and agree that the early steps of the glycogen synthesis 













Figure 24. Effect of peach phenolic fractions on intracellular glucose 6-phosphate 
concentration. G6P (A) and net insulin stimulated G6P (B) were measured. Cells were 
treated with 0.5 mM of palmitic acid during 48 h to induce insulin resistance and treated 
with fractions from peach co-incubated with palmitic acid for an additional 16 h, before 
exposure to 100 nM of insulin for 30 min. Samples were collected immediately after 
exposure to insulin. Glucose-6-phosphate was determined using a commercial kit. Each 
fraction dosage was in µl/ml. Bars are means ± S.D. (n= 3). Different letters denotes 






 Here from the results on glucose uptake it is predicted that fractions 1 and 
fractions 2 would have the highest G6P production. This theory is proven true with 
fraction 2, with levels comparable to metformin, but not exactly for fraction one. This 
could be due to the fraction compounds acting not only on the insulin signaling pathway, 
affecting the amount of glucose uptake into the cell, but also perhaps directly on 
hexokinase as well. If the intracellular glucose levels and the amount of intracellular 
G6P seem proportionate than glucose transport is most likely a target for the fractions 
but if the intracellular glucose levels are high but do not correspond to a proportionate 
G6P level then hexokinase activity must be reduced.119 Hexokinase II activity is known 
to be reduced in insulin resistance120 and since fraction 2 shows proportionate glucose 
uptake and G6P it could also be acting on hexokinase activity as well.  
3.4.7 Effect of Peach Fractions on Intracellular ROS Production 
  Palmitic acid is known for its ability to induce ROS in cellular tissues, including 
muscle.121-124 ROS production is toxic for cells at certain levels. Intracellular ROS 
production from palmitic acid can lead to an increase in ER stress that leads to a 
production in JNK, which disrupts the insulin signaling pathway and, in part, may be a 








  There have been many papers that cite that mitochondrial SOD production 
precedes insulin resistance with ROS inhibiting IRS and AKT activity while activating 
JNK phosphorylation. Mitochondrial b-oxidation also leads to increased levels of ROS 
in the skeletal muscle. Inevitable, oxidative stress due to ROS can cause cross talk and 
decrease insulin signaling pathways. Excessive ROS overwhelms AOX defenses and 
increases more oxidative stress in the system. It was determined to view the antioxidant 
potential of the peach fractions on skeletal muscle cells. Results showed that the four 
fractions had no statistically significant difference with the control cells with palmitic 
acid. Prolonged exposure (48 hours to palmitic acid induces a significant increase in the 
amount of intracellular ROS production; however acute (16 hour) treatments of 
antioxidants (vitamin E) can reduce ROS, but not drastically enough to return to the 
original control cell state (figure 25). Future studies should evaluate the effects of 













Figure 25. Peach fractions on C2C12 intracellular ROS production. Differentiated cells 
were exposed to 0.5 mM palmitic acid for 48 hours and treated with peach fractions co-
incubated with palmitic acid for an additional 16 hours. Cells  were washed two times 
with warm PBS and then incubated with 5 uM DCFA in  DMEM 1mM glucose phenol 
red-free medium at 37oC for 30 minutes and the fluorescence was measured Ex/Em 
485/535. Fraction concentrations are expressed in µg CAE/ml. Vitamin E (tocopherol) 
was used as a positive control. Reported values are relative means ± S.E. (n= 8). 
Different letters show significant differences using one-way analysis of variance 
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 While it seems that our model is not working though ROS it is important to point 
out that after each treatment with palmitate for 48 hours to induce insulin resistance 
within the cells the treatment is given for 16 hours for each of the bioassays. To keep in 
the same variables with the other assays the same protocol was followed for intracellular 
ROS, however, to view the activity that the fractions have on intracellular ROS at 48 
hours a treatment should be given after 32 hours of palmitic acid exposure and 
measurement of the intracellular ROS taken at the time point of 48 hour exposure to 
ROS (with 16 hour exposure to the treatment).  Figure 25 is showing ROS accumulation 
in the cells after 64 hour exposure to palmitic acid (with 16 hours of treatment). After 64 
hours it is likely that the ROS levels intracellularly are so high that any AOX activity 
that the phenolic compounds possess were depleted moments after initial treatment and 
therefore we see no change in the ROS levels from any of the treatments, so it is 
unknown whether our phenolic treatments are acting through a ROS pathway at least 
partly and a further initial assay done at 48 hour exposure to palmitic acid with treatment 
should be performed as well as other necessary assay testing to determine if  the 
phenolic antioxidants have any effect on ROS. 
3.4.8 Protein Expression of C2C12 Myoblasts 
 With the determination that the insulin resistant model is affecting the earlier 
stages of the insulin signalling pathways, protein expression of AKT, IRS1, and JNK 
were performed as described above.  During the insulin signaling pathway, AKT 
becomes phosphorylated as part of a cascade of events leading ultimately to glucose 




pathway. It is required to induce glucose transport. When the muscle cells are incubated 
with palmitic acid during 48 hours, the insulin signaling pathway is impaired and the 
AKT activation is inhibited inducing an insulin resistant model.125-126 therefore, is 
necessary to find compounds to able of induce the AKT activation as Metformin. In our 
results we found that only F3 and F4 increase significantly the AKT activation. This 
result is promissory to find natural compounds able to reduce the effects related to type 
2-diabetes. Out of the fraction samples, fraction 3 showed the most increase in serine 




Figure 26. Western Blot of specific peach phenolic fractions on AKT activation in 









Figure 27. Effect of specific peach phenolic fractions on AKT activation in muscle cells 
(C2C12). Cells were treated with 0.5 mM of palmitic acid for 48 hours to induce insulin 
resistance and then treated with peach phenolics fractions co-incubates with palmitic 
acid for 16 hours, previous to be exposed to 100 nM of insulin for 10  minutes before 
assay. The western blot images are representative of three independent experiments. 
Bars are means ± S.E. (3= 5). Different letters denotes significant differences using one-
way analysis of variance followed by tukey-kramer HSD .(P < 0.05) 
 
 
 In comparison with previous results, fraction 3 did not increase the glucose 
uptake and intracellular G6P concentration as well as the other fractions. Fraction 3 may 
possibly be working through the serine phosphorylation of AKT to increase glucose 




may be working through various other proteins to increase the sensitivity of the pathway 
to give the resulting increased in glucose into the cell. 
 Insulin receptor substrate-1 (IRS) plays a key role in transmitting signals from 
the insulin and insulin-like growth factor-1 receptors to intracellular pathway 
PI3K/AKT.  IRS-1 contains many potential serine phosphorylation sites, such as ser307 
and ser318 that are thought to play regulatory roles during insulin signaling. One of 
these sites, Ser307 in rat IRS-1, was originally found to be phosphorylated specifically by 
JNK. Ser307 was later found to be phosphorylates in IRS-1 isolated from cells and tissues 
stimulated with TNF-α, insulin/IGF-1, or anisomycin, which might contribute to 
peripheral insulin resistance and type 2 diabetes. 125-128In our results we found that all the 
peach phenolic fractions decrease significantly the IRS serine 307 phosphorylation 
(Figures 28-29) in our muscle cell insulin resistant model. This result is promissory 
because a reduction in the serine phosphorylation is able to reduce the effects related to 
type 2-diabetes. IRS ser318 was also measured in our studies as it is referenced as a 
potential target for JNK and other kinases. In our results we found no band activation on 
this serine residue (data not shown) displaying that this particular serine site is not 
activated in our insulin resistant model or with our treatments. In the insulin signaling 
pathway, IRS1 threonine phosphorylation triggers the downstream activation pathway 
through AKT, however, serine phosphorylation at ser307 inhibits IRS1 activation by 
interfering with the phosphor-tyrosine binding (PTB) thus inhibiting the pathway 
cascade further. 129 The serine 307 phosphorylation (ser307) of IRS1 was increased in 




treated cells, and fraction treated cells all showed similar decreased ser307 activation 
compared to palmitic acid control cells. Metformin and the four peach fractions are able 
to reverse the activation of ser307 induced by palmitic acid in the cells.  Under insulin 
stimulation is it normal to see slight IRS1 serine phosphorylation by control cells, as 
ser307 is a negative regulator of the insulin signaling pathway, however too much serine 
phosphorylation is detrimental to the signaling pathway (like the activation triggered by 
palmitic acid). It is important to note that under normal cell conditions without insulin 
stimulation there is no IRS1 phosphorylation however cells treated with metformin 
without insulin stimulation do show a slight activation of ser307, and more so with 
insulin stimulation. The phenolic fractions decrease the amount of activation as 
compared to cells treated with palmitic acid with fraction 3 showing similar results as 










Figure 28.  Western Blot of specific peach phenolic fractions on IRS1 activation in 









Figure 29.  Effect of specific peach phenolic fractions on IRS1 activation in muscle cells 
(C2C12). Cells were treated with 0.5 mM of palmitic acid during 48 hours to induce 
insulin resistance and then treated with peach phenolics fractions co-incubated with 
palmitic acid for 16 hours, previous to be exposed to 100 nM of insulin for 10 minutes 
before assay. The western blot images are representative of three independent 
experiments. Bars are means ± S.E. (3= 5). Different letters denotes significant 









 Inflammatory signals, changes in levels of reactive oxygen species, ultraviolet 
radiation, protein synthesis inhibitors, and a variety of stress stimuli can activate JNK. 
One way this activation may occur is through disruption of the conformation of sensitive 
protein phosphatase enzymes; specific phosphatases normally inhibit the activity of JNK 
itself and the activity of proteins linked to JNK activation.130-131 The activation occurs 
through a dual phosphorylation of threonine (Thr) and tyrosine (Tyr) residues within a 
Thr-Pro-Tyr motif located in kinase subdomain VIII. Activation is carried out by two 
MAP kinases, MKK4 and MKK7 and JNK can be inactivated by Ser/Thr and Tyr 
protein phosphatases. It has been suggested that this signaling pathway contributes to 
inflammatory responses in mammals and insects.132-133 The oxidative stress-sensitive 
JNK pathway is known to be activated in diabetic condition and is involved in the 
progression of insulin resistance.134-135 The present study was aimed to investigate the 
effect of peach phenolic fractions on insulin sensitivity and JNK activation in muscle 
cells insulin-resistant In our results we found that all the peach phenolic fractions reduce 
significantly the JNK activation (Figures 30, 31).  This result is promissory to find 
natural compounds able to reduce the effects of palmitic acid (free fatty acid) related to 






Figure 30. Western Blot of specific peach phenolic fractions on JNK activation in 











Figure 31. Effect of specific peach phenolic fractions on JNK activation in muscle cells 
(C2C12). Cells were treated with 0.5 mM of palmitic acid for 48 hours to induce insulin 
resistance and then treated with peach phenolics fractions co-incubated with palmitic 
acid for 16 hours, previous to be exposed to 100 nM of insulin for 10 minutes before 
assay. The western blot images are representative of three independent experiments. 
Graph is representative of both isomers of JNK. Bars are means ± S.E. (3= 5). Different 
letters denotes significant differences using one-way analysis of variance followed by 











 The results for JNK proteins show two bands in the western blot. This is due to 
the JNK protein having 2 isomers, one approximately 46 Kda and the other 54 Kda.136 
There is no differences between the two isoforms and both should be reported which is 
the case in many publications concerning JNK. From the above results of these sets of 
experiments, it shows that the positive control metformin works very well against this 
insulin resistant model, with positive effects on p-AKT activation, IRS1 ser307 
reduction, and p-JNK reduction. All fractions of peach also showed beneficial effects on 
protein expression, at p-AKT activation and IRS1ser307 reduction, with fraction 3 being 
the most effective at activation p-AKT of all the fractions. In JNK activation, all 
fractions showed statistically the same level of reduction as metformin and the control 
cells level of JNK 
 From various concentrations of phenolic compounds tested, the concentration of 
phenolics that presented the highest increase in glucose uptake in the myotubes were 
used for further studies into ROS, G6P, and protein expression. From the compilation of 
these results, we can see possible areas where the peach phenolic fractions could be 
working to prevent IR skeletal muscle. As all fractions showed an increase in glucose 
uptake in myotubes, we can assume that each fraction is acting somewhere in the insulin 
signaling pathway, however, the fraction results from the G6P production and protein 
expression were not the same in levels, suggesting that the different categories of 
phenolic compounds are working in different areas of the insulin signaling pathway. The 




 Our positive control, metformin, is known to increase insulin sensitivity and 
reverse the effects of insulin resistance by working through AMPK activation. AMPK 
acts to change the AMP: ATP ratio in the cell, to stimulate catabolic pathways (glucose 
uptake, fatty acid oxidation) and inhibit anabolic pathways (synthesis). AMPK also 
works to up-regulate glucose transporters.137 Metformin stimulates phosphorylation of 
the key regulatory site (Thr-172) on AMPK α2 catalytic subunits.138How metformin acts 
specifically on AMPK is still unknown. Recent proposed mechanism on how metformin 
phosphorylate AMPK includes proposing it acts by stimulating phosphorylation by 
upstream kinases of AMPK (AMPKK1 and AMPKK2) or by inhibiting de-
phosphorylation by protein phosphatases.139  Another theory is that metformin acts as an 
inhibitor of complex I of the respiratory chain complex.140 However, recent findings 
using cell culture have proved these theories false  as metformin did not stimulate 
activation of AMPK in cell-free assays by either of the two upstream kinases measured 
in their experiment (AMPKK1 or AMPKK2) and did not affect the cellular ADP to ATP 
ratio.138 These researchers suggest metformin could be working through other upstream 
kinases other than AMPKK1 and AMPKK2 of the drug is modified inside the cell to an 
active form.138AMPK phosphorylation works at reversing insulin resistance by 
activating AKT, GLUT4, regulating PI3K and IRS-1, increasing hexokinase activity and 
inhibiting mTOR activation, all key parts of cellular mechanisms that affect insulin 
signaling and glucose uptake.141-145  In regards to insulin signaling, AMPK activation 
increases glucose uptake in two major ways. AMPK can directly stimulate GLUT4 




leads to the inhibition of mTOR, a ser/thr protein kinase that activates IRS1 serine 
phosphorylation, negatively regulating insulin signaling.  Metformin is also known to 
inhibit the production of intracellular ROS, a key player in the development of insulin 
resistance, most likely through AMPK induced PGC1a activity leading to SOD 
production.146 Increasing ROS is a negative regulator of insulin signaling and a mediator 
of insulin resistance development. ROS generation occurs normally in the cell through 
an NADPH oxidase dependent mechanism, but over production can be triggered by 
several mechanisms including an overabundance of free fatty acids.147 JNK activation 
for prolonged periods requires an overproduction of intracellular ROS which inactivate 
JNK phosphatases.148 JNK activation by ROS promotes IRS1 ser307 phosphorylation 
which reduces the tyrosine phosphorylation of IRS1, leading to impairment in the insulin 
signaling pathway.149-152 Studies show that GLUT4 mRNA and protein levels remain 
unchanged in muscle from normal as well as insulin resistant tissues indicating that the 
decreased glucose uptake is caused by impaired signaling promoting GLUT4 
mobilization.153-154 AMPK activation by metformin may also work though other 
mechanisms of action to increase glucose uptake in muscle, such as directly though 
GLUT4 mobilization, increasing hexokinase activity, and perhaps though preventing the 
inhibition of JNK phosphatases.155-156 It has been proven difficult to identify one single 
signaling step mediating insulin resistance mediated solely by exposure to oxidants such 
as ROS as each signaling step functions as a complex network and not as a linear 
reaction chain as well as oxidant overproduction being only one of many negative 




aspects of insulin signaling to view possible mechanisms of treatments work. While 
ROS induced JNK production is a major player in insulin resistance development, 
studies show that treatment with JNK inhibitors only partially reduced insulin resistance, 
implying that there are also additional determinants to development of the syndrome.158 






Figure 32. Diagram of metformin mechanism of action on insulin resistant muscle. 
Metformin activates AMPK in the cell which works directly on glucose transporter 
mobility as well as inhibiting mTOR activity in the cell, which works through the 
activation of S6K1 for IRS1 serine phosphorylation, inhibiting insulin receptor tyrosine 




 In our results we show that while palmitic acid induced ROS overproduction 
occurs in the cell and is a major player in the development of insulin resistance, at our 48 
hour testing period none of the peach fractions were able to decrease ROS levels. If the 
fractions are working as antioxidants on ROS production, then perhaps at this time frame 
of testing their antioxidant activity has been depleted and further ROS inhibition has 
stopped. As the phenolic fractions are able to reduce other aspects of ROS induced 
insulin resistance such as JNK activation they could be working through AMPK 
preventing the inactivation of JNK phosphatases.156 Metformin also reduces the 
intracellular ROS accumulation in the cell by acting through AMPK.162The activation of 
JNK and IRS1 serine phosphorylation are directly linked, as JNK activates the IRS1 
activation. This is seen true in our results for JNK and IRS1ser307 phosphorylation in 
muscle showing similar results in low activation for normal cells, high activation for 
palmitic acid induced cells, and slightly less activation for metformin and peach fraction 
cells, with all treatments showing similar reduction in activation levels similar to 
metformin. These results could indicate the phenolic compounds are working in a 
mechanism similar to metformin on JNK activation. The same trend is seen for AKT 
activation as well with the phenolic fractions all increasing the p-AKT to levels 
comparable with normal non-treated cells. Only fraction 3 showed slightly statistically 
significant difference from the other fractions for p-AKT activation, however not to the 
same levels as metformin. While research has shown that metformin can act directly on 
AKT through AMPK 141 this may or may not be the case for the phenolic fraction 




phosphorylation and activation.137,147,163  Others report studying chlorogenic acid affects 
in muscle cells found that chlorogenic acid can phosphorylate AMPK and activate AKT, 
but does not enhance IRS1 association to p85 protein, a step in the insulin signaling 
pathway.109 Also, catechins and procyanidins have been shown to increase GLUT4 
mobility to the cell membrane.164 Having all of these individual compounds as well as 
showing similar effects on the biological assays, these fraction components may be 
working through many mechanisms to increase glucose uptake and insulin sensitivity. 
Like reported in the literature for quercetin and chlorogenic acid, the fractions could be 
regulating AMPK activity in the cell as well as inhibiting JNK phosphorylation, possibly 
through AMPK preventing the inactivation of JNK phosphatases, as well as behaving 
like catechin compounds and working directly on GLUT4 mobility to the cell 
membrane. While AMPK is a potential site for the compound’s activity, the insulin 
signaling pathway is a complex signaling cascade where many proteins are involved in 
the uptake of glucose. The AKT activation from positive control metformin is very high, 
even more than the normal insulin stimulated cells and while the fractions increased 
AKT activation to the level of the normal cells they did not improve activation to the 
level of metformin. One reason for this is that the phenolics work on more than one point 
of the insulin signaling cascade simultaneously. Metformin’s activation of AMPK aids 
in the activation of AKT165 and as this is the main effect of metformin the AKT 
activation can be said to be the effect of AMPK activation via metformin. While the 
fractions may be working by this activation as well, the effect on the signaling of AKT is 




possible mechanisms in which the peach fraction phenolics may be working on the 




Figure 33. Diagram of possible mechanisms of action of peach phenolic fractions in 
insulin resistant myotubes. With increased AKT phosphorylation, reduced IRS1ser307 
and JNK phosphorylation, an increase in glucose uptake and G6P the phenolic fractions 
could be acting on multiple fronts to revert insulin resistance including acting directly on 
glucose transport mobility, reducing JNK activation and AKT activity. Phenolic 
fractions could be working like metformin in AMPK activation promoting glucose 
transporter mobility and inhibiting negative regulation of IRS1 serine phosphorylation.  
 
 
 In these biological cell assays we see that inducing the cells with 0.5 mM of 
palmitic acid causes inhibition of the insulin pathway, with reversal of this process with 




reported in the literature widely as a way to induce insulin resistance, However, palmitic 
acid has a low water solubility so for use in cell physiological systems must be in the 
form of a complex, usually with an albumin protein for its high affinity to fatty acids.166 
Palmitic acid complexes with albumin added to cell culture media must undergo 
absorption to the cell’s membrane, trans-membrane diffusion, and desorption from the 
cell membrane once inside the cell.166 While literature widely reports the amounts of 
palmitic acid: albumin complex treated into cell culture92-95,104-108,167-173 it has been found 
that fatty acids bound to albumins directly contribute to fatty acid metabolism in the cell 
and the amount of bound: unbound palmitic acid to albumin plays a significant role in 
how much fatty acid is absorbed into the cells.174-176 So in accordance to the literature we 
cannot say for certain the palmitic acid was taken up by the cells in its entirety, but we 
can see from our experiments palmitic acid was taken up at least in part by the 




4. SUMMARY AND CONCLUSIONS 
 
4.1 Summary 
 In summary, we have used a common compound clean-up method as a mean to 
separate and recover phenolic compounds with high yield recovery and purity for testing 
in a developed model of skeletal muscle insulin resistance using mouse C2C12 
myotubes. This determine the SPE fraction phenolics bioactive effects on cellular and 
macro-marker components in the cell with a key insight to how these compounds are 
mechanistically working in the cell. Fruit phenolics increase insulin stimulated glucose 
uptake, G6P, AKT phosphorylation, and decrease negative regulators of the insulin 
signaling pathway, IRS1 ser307 and JNK phosphorylation. In this study phenolic 
compounds had no effect on intracellular ROS accumulation. 
4.2 Conclusions 
 Stone fruit phenolics from cultivars of Rich Lady peach, Black Splendor plum, 
and Spring Bright Nectarine were extracted and purified for their use as potential 
treatments in palmitic acid induced insulin resistant C2C12 myotubes. The fruit’s 
effectiveness was analyzed by the results of insulin stimulated intracellular G6P 
production.  Extracts were purified from sugars and organic acids by SPE reverse phase 
C18 silica gel and freeze-dried. Identification and validity of the phenolic extracts was 
done by HPLC-DAD and TLC chromatography methods. Extracts used in cells were 
dissolved in DMSO and expressed at µg freeze-dried powder/mL. Final DMSO 




cytotoxicity testing, and were used at levels of 0, 10, and 100 µg/mL for glucose 6-
phosphate assay. Myoblasts were fully differentiated into mature myotubes and exposed 
to palmitic acid (0.5mM) for 48hr to induce insulin resistance before and then treated 
with fruit extracts for 16hr and stimulated with insulin (100nM) for 30 minutes. Peach 
and nectarine showed to have a significant effect on glucose 6-phosphate accumulation 
in the cells at 1 and 10 µg/mL, respectively, while plum extracts showed no significant 
effects on the cells as compared to the positive control, metformin. Peach phenolic 
extract was chosen for further analysis into the significant effect on reverting insulin 
resistance. Peach extracts were purified from sugars and organic acids by SPE reverse 
phase C18 silica gel and separated into fractions via solvent and pH affinity. A yield 
study was performed to verify the effectiveness of the SPE methodology, resulting in an 
85% yield recovery of phenolic compounds after purification. Identification of phenolic 
compounds in the peach fractions was done by HPLC-DAD and fractions quantified by 
wet based chemistry assay (Folin method) and expressed as µg Chlorogenic Acid 
Equivalent/mL. Myoblasts were fully differentiated into mature myotubes and exposed 
to palmitic acid (0.5mM) for 48hr to induce insulin resistance and then treated with fruit 
extracts for 16hr and stimulated with insulin (100nM) for 30 minutes prior to assays. 
Peach fractions showed no significant changes in ROS accumulation in the palmitic acid 
treated cells at any level from 0.1 to 5 µg CAE/ml but did show significant effects on 
glucose uptake, with the most pronounced effects at 1.0 µg CAE/ml for fraction 1, 0.1 
µg CAE/ml for fraction 2 and 3, and 0.5 µg CAE/ml for fraction 4. These values were 




increase G6P intracellular concentration in palmitic acid treated cells to levels similar to 
metformin, with the exception of fraction 3 which showed no difference to palmitic acid. 
This could be due in part to large sample variation for this fraction. When running 
standard t-test at 95% CI, we see that there is a difference between F3 and palmitic acid 
treated cells. In addition, all fractions were able to decrease the JNK and IRS1 ser307 
phosphorylation, both negative regulators of the insulin pathway. The fraction 
compounds could be working on multiple fronts, working similarly to metformin 
through AMPK activation, working directly on GLUT4, AKT, or IRS1 association with 
p85. As AMPK regulates JNK and IRS1 phosphorylation, which has a direct effect on 
AKT phosphorylation, the phenolic fractions could be regulating insulin signaling 
proteins through AMPK activation. Further research is needed to investigate the 
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